{"gene":"ATP6AP1","run_date":"2026-04-28T17:12:37","timeline":{"discoveries":[{"year":1996,"finding":"ATP6AP1 (Ac45) was identified as chromaffin granule membrane glycoprotein IV and confirmed to be a membrane-integral subunit of the granule V-ATPase. Amino acid sequencing showed that Ac45/glycoprotein IV is derived from a larger precursor by removal of a 246-amino acid N-terminal sequence, yielding a mature ~29 kDa polypeptide. Blue Native electrophoresis confirmed its incorporation into the membrane sector (V0) of the V-ATPase.","method":"Membrane fractionation, lectin affinity chromatography, amino acid sequencing, enzymatic deglycosylation, Blue Native electrophoresis","journal":"Neuroscience letters","confidence":"High","confidence_rationale":"Tier 1 — direct biochemical purification and sequencing with structural confirmation by native electrophoresis","pmids":["8961292"],"is_preprint":false},{"year":1998,"finding":"ATP6AP1 (Ac45) localizes to the plasma membrane and a juxtanuclear vacuolar compartment, and is rapidly retrieved from the cell surface via endocytosis. The 26-residue cytoplasmic tail of Ac45 contains an autonomous internalization signal distinct from canonical tyrosine- or di-leucine-based motifs; multiple sites in the membrane-distal region of the tail are required for internalization.","method":"Steady-state immunolabeling, antibody internalization experiments, expression of carboxy-terminally truncated Ac45 mutants, immunolocalization in transfected CV-1 fibroblasts","journal":"Journal of cell science","confidence":"High","confidence_rationale":"Tier 2 — direct localization experiments with functional mutagenesis of sorting signal in multiple deletion constructs","pmids":["9739073"],"is_preprint":false},{"year":1999,"finding":"Xenopus ATP6AP1 (Ac45) is synthesized as an N-glycosylated ~60 kDa precursor that is intracellularly cleaved to a ~40 kDa C-terminal product, with the processed form predominating in neuroendocrine tissues. Ac45 is highly expressed in biosynthetically active melanotrope cells of the intermediate pituitary, consistent with a role in acidification of neuroendocrine secretory granules.","method":"Western blot, biosynthetic labeling, deglycosylation, immunocytochemistry in Xenopus pituitary","journal":"European journal of biochemistry","confidence":"High","confidence_rationale":"Tier 2 — biosynthetic studies with deglycosylation and direct tissue immunolocalization; replicated in neuroendocrine context","pmids":["10336633"],"is_preprint":false},{"year":2002,"finding":"Targeted disruption of the Ac45 (ATP6AP1) gene in mouse embryonic stem cells produced Ac45 null mutant (−/Y) ES cells. Injection into blastocysts led to severely impaired development, with only one low-chimeric female born that died at 6 weeks; no late abortions were detected. Results indicate that Ac45 null ES cells disrupt normal blastocyst development, consistent with an essential role for V-ATPase in early embryogenesis.","method":"Gene targeting by homologous recombination in ES cells, blastocyst injection, chimera analysis","journal":"Molecular membrane biology","confidence":"High","confidence_rationale":"Tier 2 — clean genetic knockout with defined developmental phenotype","pmids":["11989824"],"is_preprint":false},{"year":2002,"finding":"Newly synthesized ATP6AP1 (Ac45) is N-glycosylated to ~62 kDa and ~64 kDa forms; glycan trimming produces ~61 and ~63 kDa forms that are cleaved to a C-terminal ~42–44 kDa fragment and a previously undetected ~22 kDa N-terminal fragment. Cleavage occurs early in the secretory pathway (brefeldin A- and monensin-insensitive), has a half-life of 4–6 h, and requires proper N-glycosylation-dependent folding. The N-terminal fragment is rapidly degraded in a non-lysosomal, brefeldin A-sensitive compartment.","method":"Biosynthetic pulse-chase labeling, pharmacological inhibitors (brefeldin A, monensin, tunicamycin), endoglycosidase H resistance assay in neuroendocrine cells","journal":"European journal of biochemistry","confidence":"High","confidence_rationale":"Tier 1/2 — detailed biosynthetic analysis with orthogonal pharmacological dissection of cleavage site and kinetics","pmids":["11952786"],"is_preprint":false},{"year":2008,"finding":"Transgenic overexpression of ATP6AP1 (Ac45) specifically in Xenopus melanotrope cells caused accumulation of the V-ATPase at the plasma membrane, increased abundance of secretory granules, plasma membrane protrusions, and enhanced Ca2+-dependent peptide secretion. Ac45 transgene did not alter levels of prohormone POMC or V-ATPase subunits, indicating Ac45 guides the V-ATPase through the secretory pathway to regulate Ca2+-dependent exocytosis.","method":"Transgenic Xenopus melanotrope cell model, immunofluorescence, electron microscopy, Ca2+-dependent secretion assay","journal":"Biochimica et biophysica acta","confidence":"High","confidence_rationale":"Tier 2 — in vivo transgenic gain-of-function with multiple orthogonal readouts (localization, ultrastructure, secretion)","pmids":["18657579"],"is_preprint":false},{"year":2008,"finding":"Furin was identified as a proprotein convertase that cleaves ATP6AP1 (Ac45) in the endocrine pancreas. Furin-deficient beta cells showed significantly decreased granule acidification. Ac45 is highly expressed in islets of Langerhans, and furin cleaves Ac45 ex vivo at a defined site. Knockdown of either furin or Ac45 in insulinoma betaTC3 cells similarly reduced regulated secretion and proinsulin II processing, establishing furin as the writer of Ac45 cleavage-mediated activation.","method":"Conditional furin knockout mice (Pdx1-Cre/loxP), DAMP acidification assay, ex vivo cleavage assay, siRNA knockdown in insulinoma cells, secretion and processing assays","journal":"Proceedings of the National Academy of Sciences of the United States of America","confidence":"High","confidence_rationale":"Tier 1/2 — in vivo knockout plus ex vivo cleavage assay plus RNAi validation with multiple functional readouts","pmids":["18713856"],"is_preprint":false},{"year":2010,"finding":"Transgenic manipulation of ATP6AP1 (Ac45) levels in Xenopus melanotrope cells demonstrated that Ac45 directly regulates V-ATPase-mediated granular acidification. Elevated Ac45 significantly increased granular acidification, reduced sensitivity to the V-ATPase inhibitor bafilomycin A1, enhanced early prohormone convertase PC1-mediated POMC processing, and suppressed late PC2-mediated POMC processing by impairing neutral pH-dependent 7B2-proPC2 maturation. Ac45 was established as the first identified regulator of the V-ATPase proton pump.","method":"Transgenic Xenopus melanotrope cell model, acidotrophic dye assays, bafilomycin sensitivity, immunoblot analysis of POMC processing intermediates","journal":"Molecular biology of the cell","confidence":"High","confidence_rationale":"Tier 2 — in vivo transgenic model with multiple orthogonal functional readouts; first mechanistic demonstration of Ac45 as V-ATPase regulator","pmids":["20702583"],"is_preprint":false},{"year":2012,"finding":"ATP6AP1 (Ac45) is essential for osteoclast-mediated extracellular acidification, bone resorption, lysosomal trafficking to the ruffled border, and cathepsin K exocytosis. Ac45 knockdown osteoclasts formed normal actin rings but failed to acidify extracellular space and exhibited absent lysosomal trafficking and cathepsin K exocytosis. The impaired exocytosis was specific to Ac45 deficiency, not a general V-ATPase defect. Ac45 was shown to interact with the small GTPase Rab7, suggesting a mechanism for lysosomal trafficking guidance. Ac45 knockdown also reduced osteoclast precursor proliferation and fusion via downregulation of ERK phosphorylation, c-fos, NFATc1, and Tm7sf4.","method":"siRNA knockdown in osteoclasts, bone resorption assay, extracellular acidification assay, lysosomal trafficking assay, cathepsin K exocytosis assay, co-immunoprecipitation with Rab7, RANKL-induced differentiation","journal":"Journal of bone and mineral research","confidence":"High","confidence_rationale":"Tier 2 — loss-of-function with multiple specific cellular phenotype readouts and co-IP evidence for Rab7 interaction","pmids":["22467241"],"is_preprint":false},{"year":2012,"finding":"Domain mapping in Xenopus melanotrope cells identified that the N-terminal domain of intact Ac45 causes ER retention and poor processing, while proteolytic cleavage (generating cleaved-Ac45) enables efficient transport through the secretory pathway and V-ATPase accumulation at the plasma membrane. Removal of the C-tail from cleaved-Ac45 still permitted plasma membrane transport but abolished V-ATPase recruitment into the secretory pathway and abrogated dopaminergic inhibition of Ca2+-dependent peptide secretion. The C-tail of cleaved-Ac45 is thus specifically required for V-ATPase recruitment and regulation of Ca2+-dependent exocytosis.","method":"Transgenic Xenopus melanotrope cells expressing deletion mutants of Ac45, immunofluorescence, electron microscopy, secretion assays","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 2 — systematic deletion mutagenesis in physiological in vivo context with multiple functional endpoints","pmids":["22736765"],"is_preprint":false},{"year":2016,"finding":"ATP6AP1 (Ac45) was identified as the functional human ortholog of yeast V-ATPase assembly factor Voa1. Eleven male patients with hemizygous missense mutations in ATP6AP1 displayed immunodeficiency with hypogammaglobulinemia, hepatopathy, and neurocognitive abnormalities. Processed wild-type Ac45, but not disease mutants, restored V-ATPase-dependent growth in Voa1 mutant yeast. Tissue-specific isoforms were identified: ~40 kDa processed form in brain, ~62 kDa intact form in liver, and ~50 kDa isoform in B cells, linking tissue-specific V-ATPase assembly to immunoglobulin production and cognitive function.","method":"Whole-exome sequencing, yeast complementation assay (Voa1 mutant rescue), Western blot of patient tissues, glycosylation analysis, homology detection via sequence profile comparison","journal":"Nature communications","confidence":"High","confidence_rationale":"Tier 1/2 — yeast complementation plus patient genetics plus multiple orthogonal biochemical analyses; functionally defines Ac45 as V-ATPase assembly factor","pmids":["27231034"],"is_preprint":false},{"year":2018,"finding":"Whole-exome sequencing revealed mutually exclusive, clonal, inactivating somatic mutations in ATP6AP1 or ATP6AP2 in 72% of granular cell tumors (GCTs). In vitro silencing of ATP6AP1 resulted in impaired vesicle acidification, redistribution of endosomal compartments, accumulation of intracytoplasmic granules (recapitulating GCT histology), and acquisition of oncogenic properties, demonstrating that ATP6AP1 loss-of-function drives GCT tumorigenesis.","method":"Whole-exome sequencing, targeted sequencing, siRNA knockdown, lysosomal acidification assay (LysoSensor), endosomal compartment immunofluorescence, proliferation/migration/invasion assays","journal":"Nature communications","confidence":"High","confidence_rationale":"Tier 2 — genomic discovery validated by in vitro loss-of-function with multiple orthogonal cellular phenotype readouts","pmids":["30166553"],"is_preprint":false},{"year":2022,"finding":"SARS-CoV-2 NSP6 directly interacts with ATP6AP1, a V-ATPase proton pump component, and inhibits its cleavage-mediated activation, thereby impairing lysosome acidification and blocking autophagic flux, which triggers NLRP3/ASC-dependent caspase-1 activation, IL-1β/18 maturation, and pyroptosis in lung epithelial cells. The L37F NSP6 variant (associated with asymptomatic COVID-19) showed reduced binding to ATP6AP1 and weakened ability to impair lysosome acidification. Restoration of autophagic flux by 1α,25-dihydroxyvitamin D3, metformin, or polydatin abrogated NSP6-induced pyroptosis.","method":"Co-immunoprecipitation, overexpression/knockdown studies, lysosomal acidification assay, autophagic flux assay, caspase-1 activation assay, cytokine maturation assay, live SARS-CoV-2 infection, transcriptome analysis, pharmacological rescue","journal":"Cell death and differentiation","confidence":"High","confidence_rationale":"Tier 2 — direct co-IP interaction, variant binding comparison, multiple downstream functional readouts, pharmacological validation, and live virus confirmation","pmids":["34997207"],"is_preprint":false},{"year":2024,"finding":"ATP6AP1 was identified as an unconventional guanine nucleotide exchange factor (GEF) for the small G protein Rheb, which directly activates mTORC1. Using proximity labeling (PhastID), ATP6AP1 was found to dynamically interact with Rheb in an insulin-stimulated manner. ATP6AP1 binds Rheb through its last 12 amino acids and utilizes a tri-aspartate motif in its highly conserved C-tail to enhance Rheb GTP loading. Targeting the ATP6AP1 C-tail blocked Rheb activation and inhibited cancer cell proliferation and migration, filling the missing link in the Rheb/mTORC1 activation pathway.","method":"PhastID proximity labeling, co-immunoprecipitation, in vitro GEF activity assay (GTP loading), deletion/mutagenesis analysis of C-tail, cancer cell proliferation and migration assays","journal":"Cell research","confidence":"High","confidence_rationale":"Tier 1/2 — proximity labeling discovery validated by co-IP, in vitro GEF assay, mutagenesis of functional motif, and cellular functional consequences","pmids":["38448650"],"is_preprint":false},{"year":2015,"finding":"Local AAV-mediated knockdown of ATP6AP1 (Ac45) in a periodontitis mouse model protected mice from bone erosion by >85%, reduced osteoclast-mediated extracellular acidification and bone resorption in vitro and in vivo, and attenuated gingival inflammation including decreased infiltration of T cells, dendritic cells, and macrophages, and reduced pro-inflammatory cytokine expression.","method":"AAV-mediated shRNA knockdown in mouse periodontitis model (P. gingivalis W50), histology, immunochemistry, ELISA, qRT-PCR, in vitro osteoclast acidification assay","journal":"Journal of clinical periodontology","confidence":"Medium","confidence_rationale":"Tier 2 — in vivo loss-of-function with defined bone and inflammatory phenotypes; single lab study","pmids":["25952706"],"is_preprint":false}],"current_model":"ATP6AP1 (Ac45) is a type I transmembrane accessory subunit of the V-ATPase V0 sector that undergoes furin-mediated proteolytic cleavage to become activated; the processed form guides V-ATPase trafficking through the secretory pathway, directly regulates intra-organellar (lysosomal/granular) acidification, and controls Ca2+-dependent exocytosis in neuroendocrine cells and lysosomal trafficking via Rab7 in osteoclasts; it functions as the human ortholog of yeast V-ATPase assembly factor Voa1; it additionally acts as an unconventional GEF for Rheb, thereby integrating mTORC1 activation signals at the lysosomal surface; and its interaction with SARS-CoV-2 NSP6 is exploited to impair lysosome acidification and trigger NLRP3-dependent pyroptosis, while its inactivation drives granular cell tumor oncogenesis."},"narrative":{"teleology":[{"year":1996,"claim":"Establishing ATP6AP1 as a V-ATPase subunit resolved the identity of chromaffin granule glycoprotein IV and placed it within the V0 membrane sector, opening the question of what regulatory role an accessory subunit plays in proton pump function.","evidence":"Biochemical purification, amino acid sequencing, and Blue Native electrophoresis of bovine chromaffin granule membranes","pmids":["8961292"],"confidence":"High","gaps":["No functional assay for pump activity modulation","Cleavage site and protease not yet defined","Mechanism of V0 incorporation unknown"]},{"year":1999,"claim":"Demonstrating that Ac45 is synthesized as a glycosylated precursor cleaved to a mature form enriched in neuroendocrine tissues established a biosynthetic framework and suggested that proteolytic processing activates the protein for its V-ATPase regulatory role.","evidence":"Biosynthetic pulse-chase labeling, deglycosylation, and immunocytochemistry in Xenopus pituitary; complemented by pharmacological dissection in 2002","pmids":["10336633","11952786"],"confidence":"High","gaps":["Identity of the protease responsible for cleavage unknown","Functional consequence of cleavage not yet tested"]},{"year":2002,"claim":"Gene targeting showed that Ac45 is essential for mouse embryonic development, establishing it as a non-redundant gene required for fundamental cellular viability rather than a dispensable accessory factor.","evidence":"Homologous recombination knockout in ES cells with blastocyst injection chimera analysis","pmids":["11989824"],"confidence":"High","gaps":["Mechanism of embryonic lethality uncharacterized","Tissue-specific requirements not dissected","No conditional knockout to separate early vs. late functions"]},{"year":2008,"claim":"Two advances established the mechanistic basis of Ac45 function: transgenic overexpression showed Ac45 guides V-ATPase to the plasma membrane and enhances Ca²⁺-dependent exocytosis, while identification of furin as the activating protease linked cleavage to granule acidification and regulated secretion in pancreatic beta cells.","evidence":"Transgenic Xenopus melanotrope cells with EM, secretion assays; conditional furin knockout mice with ex vivo cleavage assay and siRNA knockdown in insulinoma cells","pmids":["18657579","18713856"],"confidence":"High","gaps":["Structural basis of furin recognition site not resolved","Whether other proprotein convertases can substitute for furin in vivo"]},{"year":2010,"claim":"Direct measurement of granular pH established Ac45 as the first identified positive regulator of V-ATPase proton pumping, showing it controls differential prohormone processing by tuning compartmental acidity.","evidence":"Acidotrophic dye assays and bafilomycin sensitivity in transgenic Xenopus melanotrope cells with immunoblot of POMC processing intermediates","pmids":["20702583"],"confidence":"High","gaps":["Whether Ac45 alters V-ATPase catalytic rate vs. surface density not distinguished","No reconstituted in vitro pump activity assay"]},{"year":2012,"claim":"Domain mapping revealed that furin cleavage liberates the processed form for efficient secretory pathway transit, and that the cytoplasmic C-tail is specifically required for V-ATPase recruitment and regulation of exocytosis, defining the minimal functional architecture of Ac45.","evidence":"Systematic deletion mutagenesis of Ac45 domains in transgenic Xenopus melanotrope cells with localization and secretion readouts","pmids":["22736765"],"confidence":"High","gaps":["Binding partners of the C-tail not identified","Structural basis of C-tail–V-ATPase interaction unknown"]},{"year":2012,"claim":"Extending Ac45 function to osteoclasts showed it is required for extracellular acidification, bone resorption, and cathepsin K exocytosis via interaction with Rab7, demonstrating a lysosomal trafficking guidance role beyond neuroendocrine secretion.","evidence":"siRNA knockdown in osteoclasts with bone resorption, extracellular acidification, lysosomal trafficking, and cathepsin K exocytosis assays; co-immunoprecipitation with Rab7","pmids":["22467241"],"confidence":"High","gaps":["Direct vs. indirect nature of Rab7 interaction not resolved","No structural data on Ac45–Rab7 interface","Rab7 GEF/GAP mechanism not tested"]},{"year":2015,"claim":"In vivo AAV-mediated knockdown of Ac45 in a periodontitis model validated the osteoclast findings and revealed additional anti-inflammatory effects, suggesting broader roles in immune cell regulation at sites of bone erosion.","evidence":"AAV-shRNA knockdown in mouse periodontitis model with histology, immunochemistry, cytokine profiling, and in vitro osteoclast assays","pmids":["25952706"],"confidence":"Medium","gaps":["Single-lab study not independently replicated","Inflammatory effects may be secondary to impaired osteoclast function rather than direct immune regulation","Off-target AAV effects not fully excluded"]},{"year":2016,"claim":"Identification of ATP6AP1 as the human ortholog of yeast Voa1 and discovery that hemizygous missense mutations cause X-linked immunodeficiency with hepatopathy and neurocognitive disease unified the V-ATPase assembly function with human pathology and revealed tissue-specific Ac45 isoforms.","evidence":"Whole-exome sequencing of 11 male patients, yeast Voa1 complementation assay with wild-type vs. mutant Ac45, Western blot of patient tissues","pmids":["27231034"],"confidence":"High","gaps":["Structural basis of disease-causing mutations not determined","Tissue-specific isoform generation mechanism unknown","No mouse model recapitulating the full human phenotype"]},{"year":2018,"claim":"Discovery of recurrent somatic inactivating mutations in ATP6AP1 in granular cell tumors, validated by silencing-induced impaired acidification and oncogenic phenotypes, established ATP6AP1 as a tumor suppressor whose loss drives a specific tumor type.","evidence":"Whole-exome and targeted sequencing of GCTs; siRNA knockdown with lysosomal acidification, endosomal redistribution, and proliferation/migration/invasion assays","pmids":["30166553"],"confidence":"High","gaps":["Mechanism linking impaired acidification to oncogenic transformation not defined","No in vivo tumor model with Ac45 loss","Relationship between GCT mutations and V-ATPase assembly not tested"]},{"year":2022,"claim":"SARS-CoV-2 NSP6 was shown to directly bind ATP6AP1 and inhibit its cleavage-mediated activation, impairing lysosome acidification and triggering NLRP3-dependent pyroptosis—revealing Ac45 as a viral target for immune evasion.","evidence":"Co-immunoprecipitation, lysosomal acidification and autophagic flux assays, caspase-1 activation, live SARS-CoV-2 infection, and pharmacological rescue in lung epithelial cells","pmids":["34997207"],"confidence":"High","gaps":["Structural interface of NSP6–ATP6AP1 interaction not resolved","Whether other coronaviruses exploit the same mechanism is untested","Relative contribution of ATP6AP1 vs. other NSP6 targets to COVID-19 pathology unclear"]},{"year":2024,"claim":"Identification of ATP6AP1 as an unconventional GEF for Rheb via its conserved C-terminal tri-aspartate motif provided a direct mechanistic link between V-ATPase-associated lysosomal signaling and mTORC1 activation, filling a long-standing gap in Rheb regulation.","evidence":"PhastID proximity labeling, co-immunoprecipitation, in vitro GEF assay, C-tail mutagenesis, cancer cell proliferation and migration assays","pmids":["38448650"],"confidence":"High","gaps":["Structural basis of Ac45–Rheb GEF activity not resolved","Whether V-ATPase proton pumping is coupled to or independent of the GEF function","In vivo genetic validation of the GEF function in animal models pending"]},{"year":null,"claim":"Key unresolved questions include the structural basis of the ATP6AP1 C-tail's dual function in V-ATPase recruitment and Rheb GEF activity, the mechanism generating tissue-specific Ac45 isoforms, and whether the V-ATPase assembly and mTORC1 signaling roles are coordinated or independent.","evidence":"","pmids":[],"confidence":"Low","gaps":["No high-resolution structure of Ac45 in complex with V0 or Rheb","Tissue-specific isoform biogenesis mechanism unknown","Coupling between proton pump regulation and mTORC1 GEF function untested"]}],"mechanism_profile":{"molecular_activity":[{"term_id":"GO:0005198","term_label":"structural molecule activity","supporting_discovery_ids":[0,10]},{"term_id":"GO:0098772","term_label":"molecular function regulator activity","supporting_discovery_ids":[5,7,9]},{"term_id":"GO:0060090","term_label":"molecular adaptor activity","supporting_discovery_ids":[8,9]},{"term_id":"GO:0060089","term_label":"molecular transducer activity","supporting_discovery_ids":[13]}],"localization":[{"term_id":"GO:0005886","term_label":"plasma membrane","supporting_discovery_ids":[1,5,9]},{"term_id":"GO:0005764","term_label":"lysosome","supporting_discovery_ids":[8,11,12]},{"term_id":"GO:0031410","term_label":"cytoplasmic vesicle","supporting_discovery_ids":[1,2,5]},{"term_id":"GO:0005783","term_label":"endoplasmic reticulum","supporting_discovery_ids":[4,9]},{"term_id":"GO:0005794","term_label":"Golgi apparatus","supporting_discovery_ids":[4,6]}],"pathway":[{"term_id":"R-HSA-382551","term_label":"Transport of small molecules","supporting_discovery_ids":[0,5,7,8]},{"term_id":"R-HSA-5653656","term_label":"Vesicle-mediated transport","supporting_discovery_ids":[5,8,9]},{"term_id":"R-HSA-162582","term_label":"Signal Transduction","supporting_discovery_ids":[13]},{"term_id":"R-HSA-1643685","term_label":"Disease","supporting_discovery_ids":[10,11]},{"term_id":"R-HSA-392499","term_label":"Metabolism of proteins","supporting_discovery_ids":[4,6,10]},{"term_id":"R-HSA-9612973","term_label":"Autophagy","supporting_discovery_ids":[12]},{"term_id":"R-HSA-168256","term_label":"Immune System","supporting_discovery_ids":[10,14]}],"complexes":["V-ATPase V0 sector"],"partners":["RAB7A","RHEB","FURIN","ATP6V0A1"],"other_free_text":[]},"mechanistic_narrative":"ATP6AP1 (Ac45) is an accessory subunit of the V0 sector of the vacuolar H⁺-ATPase that functions as a V-ATPase assembly factor, trafficking guide, and signaling integrator at endomembranes. Synthesized as an N-glycosylated precursor, it undergoes furin-mediated proteolytic cleavage in the secretory pathway; the processed C-terminal form directs V-ATPase through the secretory pathway to regulate organellar and extracellular acidification, Ca²⁺-dependent exocytosis in neuroendocrine cells, and lysosomal trafficking via Rab7 interaction in osteoclasts [PMID:18713856, PMID:20702583, PMID:22736765, PMID:22467241]. ATP6AP1 additionally acts as an unconventional guanine nucleotide exchange factor for Rheb, coupling V-ATPase-associated lysosomal signaling to mTORC1 activation through a conserved tri-aspartate motif in its cytoplasmic tail [PMID:38448650]. Hemizygous missense mutations in ATP6AP1 cause an X-linked syndrome of immunodeficiency with hypogammaglobulinemia, hepatopathy, and neurocognitive abnormalities, while somatic inactivating mutations drive granular cell tumor oncogenesis [PMID:27231034, PMID:30166553]."},"prefetch_data":{"uniprot":{"accession":"Q15904","full_name":"V-type proton ATPase subunit S1","aliases":["Protein XAP-3","V-ATPase Ac45 subunit","V-ATPase S1 accessory protein","Vacuolar proton pump subunit S1"],"length_aa":470,"mass_kda":52.0,"function":"Accessory subunit of the proton-transporting vacuolar (V)-ATPase protein pump, which is required for luminal acidification of secretory vesicles (PubMed:33065002). Guides the V-type ATPase into specialized subcellular compartments, such as neuroendocrine regulated secretory vesicles or the ruffled border of the osteoclast, thereby regulating its activity (PubMed:27231034). Involved in membrane trafficking and Ca(2+)-dependent membrane fusion (PubMed:27231034). May play a role in the assembly of the V-type ATPase complex (Probable). In aerobic conditions, involved in intracellular iron homeostasis, thus triggering the activity of Fe(2+) prolyl hydroxylase (PHD) enzymes, and leading to HIF1A hydroxylation and subsequent proteasomal degradation (PubMed:28296633). In islets of Langerhans cells, may regulate the acidification of dense-core secretory granules (By similarity)","subcellular_location":"Endoplasmic reticulum membrane; Endoplasmic reticulum-Golgi intermediate compartment membrane; Cytoplasmic vesicle, secretory vesicle, synaptic vesicle membrane; Cytoplasmic vesicle, clathrin-coated vesicle membrane","url":"https://www.uniprot.org/uniprotkb/Q15904/entry"},"depmap":{"release":"DepMap","has_data":true,"is_common_essential":true,"resolved_as":"","url":"https://depmap.org/portal/gene/ATP6AP1","classification":"Common Essential","n_dependent_lines":1132,"n_total_lines":1208,"dependency_fraction":0.9370860927152318},"opencell":{"profiled":true,"resolved_as":"","ensg_id":"ENSG00000071553","cell_line_id":"CID001917","localizations":[{"compartment":"vesicles","grade":3},{"compartment":"golgi","grade":2}],"interactors":[{"gene":"ATP6V1G1","stoichiometry":10.0},{"gene":"ATP6AP2","stoichiometry":10.0},{"gene":"VAMP7","stoichiometry":10.0},{"gene":"ATP6V1B2","stoichiometry":10.0},{"gene":"ATP6V0D1","stoichiometry":10.0},{"gene":"ATP6V0A1","stoichiometry":10.0},{"gene":"ATP6V0A2","stoichiometry":10.0},{"gene":"ATP6V1A","stoichiometry":0.2},{"gene":"ATP6V0C","stoichiometry":0.2},{"gene":"ATP6V1F","stoichiometry":0.2}],"url":"https://opencell.sf.czbiohub.org/target/CID001917","total_profiled":1310},"omim":[{"mim_id":"617098","title":"RIBONUCLEASE K; RNASEK","url":"https://www.omim.org/entry/617098"},{"mim_id":"301045","title":"CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIr; CDG2R","url":"https://www.omim.org/entry/301045"},{"mim_id":"300972","title":"IMMUNODEFICIENCY 47; IMD47","url":"https://www.omim.org/entry/300972"},{"mim_id":"300847","title":"AUTISM, SUSCEPTIBILITY TO, X-LINKED 5; AUTSX5","url":"https://www.omim.org/entry/300847"},{"mim_id":"300815","title":"CHROMOSOME Xq28 DUPLICATION SYNDROME","url":"https://www.omim.org/entry/300815"}],"hpa":{"profiled":true,"resolved_as":"","reliability":"","locations":[],"tissue_specificity":"Low tissue specificity","tissue_distribution":"Detected in all","driving_tissues":[],"url":"https://www.proteinatlas.org/search/ATP6AP1"},"hgnc":{"alias_symbol":["ORF","XAP-3","VATPS1","16A","Ac45","XAP3","CF2"],"prev_symbol":["ATP6S1","ATP6IP1"]},"alphafold":{"accession":"Q15904","domains":[{"cath_id":"-","chopping":"40-222","consensus_level":"high","plddt":81.9585,"start":40,"end":222},{"cath_id":"2.40.160.110","chopping":"257-416","consensus_level":"high","plddt":89.2051,"start":257,"end":416}],"viewer_url":"https://alphafold.ebi.ac.uk/entry/Q15904","model_url":"https://alphafold.ebi.ac.uk/files/AF-Q15904-F1-model_v6.cif","pae_url":"https://alphafold.ebi.ac.uk/files/AF-Q15904-F1-predicted_aligned_error_v6.png","plddt_mean":78.81},"mouse_models":{"mgi_url":"https://www.informatics.jax.org/marker/summary?nomen=ATP6AP1","jax_strain_url":"https://www.jax.org/strain/search?query=ATP6AP1"},"sequence":{"accession":"Q15904","fasta_url":"https://rest.uniprot.org/uniprotkb/Q15904.fasta","uniprot_url":"https://www.uniprot.org/uniprotkb/Q15904/entry","alphafold_viewer_url":"https://alphafold.ebi.ac.uk/entry/Q15904"}},"corpus_meta":[{"pmid":"16769691","id":"PMC_16769691","title":"Complete set of ORF clones of Escherichia coli ASKA library (a complete set of E. coli K-12 ORF archive): unique resources for biological research.","date":"2006","source":"DNA research : an international journal for rapid publication of reports on genes and genomes","url":"https://pubmed.ncbi.nlm.nih.gov/16769691","citation_count":1153,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"17108024","id":"PMC_17108024","title":"Severe acute respiratory syndrome coronavirus open reading frame (ORF) 3b, ORF 6, and nucleocapsid proteins function as interferon antagonists.","date":"2006","source":"Journal of virology","url":"https://pubmed.ncbi.nlm.nih.gov/17108024","citation_count":535,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"3118220","id":"PMC_3118220","title":"HIV F/3' orf encodes a phosphorylated GTP-binding protein resembling an oncogene product.","date":"1987","source":"Nature","url":"https://pubmed.ncbi.nlm.nih.gov/3118220","citation_count":521,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"11814675","id":"PMC_11814675","title":"ORF-FINDER: a vector for high-throughput gene identification.","date":"2002","source":"Gene","url":"https://pubmed.ncbi.nlm.nih.gov/11814675","citation_count":306,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"14671098","id":"PMC_14671098","title":"Genomes of the parapoxviruses ORF virus and bovine papular stomatitis virus.","date":"2004","source":"Journal of virology","url":"https://pubmed.ncbi.nlm.nih.gov/14671098","citation_count":232,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"19363029","id":"PMC_19363029","title":"Transmembrane protein 16A (TMEM16A) is a Ca2+-regulated Cl- secretory channel in mouse airways.","date":"2009","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/19363029","citation_count":209,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"9689744","id":"PMC_9689744","title":"Ovine diseases. Orf.","date":"1998","source":"Veterinary research","url":"https://pubmed.ncbi.nlm.nih.gov/9689744","citation_count":188,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"34997207","id":"PMC_34997207","title":"SARS-CoV-2 non-structural protein 6 triggers NLRP3-dependent pyroptosis by targeting ATP6AP1.","date":"2022","source":"Cell death and differentiation","url":"https://pubmed.ncbi.nlm.nih.gov/34997207","citation_count":152,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"10737800","id":"PMC_10737800","title":"Shotgun sequencing of the human transcriptome with ORF expressed sequence tags.","date":"2000","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/10737800","citation_count":135,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"27231034","id":"PMC_27231034","title":"ATP6AP1 deficiency causes an immunodeficiency with hepatopathy, cognitive impairment and abnormal protein glycosylation.","date":"2016","source":"Nature communications","url":"https://pubmed.ncbi.nlm.nih.gov/27231034","citation_count":120,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"25807056","id":"PMC_25807056","title":"Molecular genetic analysis of orf virus: a poxvirus that has adapted to skin.","date":"2015","source":"Viruses","url":"https://pubmed.ncbi.nlm.nih.gov/25807056","citation_count":119,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"12297324","id":"PMC_12297324","title":"Immunity and counter-immunity during infection with the parapoxvirus orf virus.","date":"2002","source":"Virus research","url":"https://pubmed.ncbi.nlm.nih.gov/12297324","citation_count":111,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"30166553","id":"PMC_30166553","title":"Loss-of-function mutations in ATP6AP1 and ATP6AP2 in granular cell tumors.","date":"2018","source":"Nature communications","url":"https://pubmed.ncbi.nlm.nih.gov/30166553","citation_count":102,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"16339376","id":"PMC_16339376","title":"Genome annotation past, present, and future: how to define an ORF at each locus.","date":"2005","source":"Genome research","url":"https://pubmed.ncbi.nlm.nih.gov/16339376","citation_count":90,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"6279055","id":"PMC_6279055","title":"The genome of orf virus: restriction endonuclease analysis of viral DNA isolated from lesions of orf in sheep.","date":"1982","source":"Archives of virology","url":"https://pubmed.ncbi.nlm.nih.gov/6279055","citation_count":85,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"8382394","id":"PMC_8382394","title":"Phylogenetic and structural analyses of MMTV LTR ORF sequences of exogenous and endogenous origins.","date":"1993","source":"Virology","url":"https://pubmed.ncbi.nlm.nih.gov/8382394","citation_count":83,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"15731233","id":"PMC_15731233","title":"Single-amino-acid substitutions in open reading frame (ORF) 1b-nsp14 and ORF 2a proteins of the coronavirus mouse hepatitis virus are attenuating in mice.","date":"2005","source":"Journal of virology","url":"https://pubmed.ncbi.nlm.nih.gov/15731233","citation_count":80,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"10567653","id":"PMC_10567653","title":"The human herpesvirus-8 ORF 57 gene and its properties.","date":"1999","source":"The Journal of general virology","url":"https://pubmed.ncbi.nlm.nih.gov/10567653","citation_count":69,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"18713856","id":"PMC_18713856","title":"Role of furin in granular acidification in the endocrine pancreas: identification of the V-ATPase subunit Ac45 as a candidate substrate.","date":"2008","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/18713856","citation_count":67,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"23239156","id":"PMC_23239156","title":"The transmembrane protein 16A Ca(2+)-activated Cl- channel in airway smooth muscle contributes to airway hyperresponsiveness.","date":"2012","source":"American journal of respiratory and critical care medicine","url":"https://pubmed.ncbi.nlm.nih.gov/23239156","citation_count":67,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"24401903","id":"PMC_24401903","title":"Transmembrane protein with unknown function 16A overexpression promotes glioma formation through the nuclear factor-κB signaling pathway.","date":"2014","source":"Molecular medicine reports","url":"https://pubmed.ncbi.nlm.nih.gov/24401903","citation_count":66,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"3029950","id":"PMC_3029950","title":"The structure and cloning of orf virus DNA.","date":"1987","source":"Virology","url":"https://pubmed.ncbi.nlm.nih.gov/3029950","citation_count":65,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"21573056","id":"PMC_21573056","title":"Three-dimensional cryoEM reconstruction of native LDL particles to 16Å resolution at physiological body temperature.","date":"2011","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/21573056","citation_count":59,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"16514336","id":"PMC_16514336","title":"Orf virus infection and host immunity.","date":"2006","source":"Current opinion in infectious diseases","url":"https://pubmed.ncbi.nlm.nih.gov/16514336","citation_count":56,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"22467241","id":"PMC_22467241","title":"V-ATPase subunit ATP6AP1 (Ac45) regulates osteoclast differentiation, extracellular acidification, lysosomal trafficking, and protease exocytosis in osteoclast-mediated bone resorption.","date":"2012","source":"Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research","url":"https://pubmed.ncbi.nlm.nih.gov/22467241","citation_count":55,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"1329339","id":"PMC_1329339","title":"Serine protein kinase associated with varicella-zoster virus ORF 47.","date":"1992","source":"Virology","url":"https://pubmed.ncbi.nlm.nih.gov/1329339","citation_count":53,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"34871442","id":"PMC_34871442","title":"Phosphorylation of ribosomal protein S6 differentially affects mRNA translation based on ORF length.","date":"2021","source":"Nucleic acids research","url":"https://pubmed.ncbi.nlm.nih.gov/34871442","citation_count":52,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"11022792","id":"PMC_11022792","title":"Sequence and functional analysis of a homolog of interleukin-10 encoded by the parapoxvirus orf virus.","date":"2000","source":"Virus genes","url":"https://pubmed.ncbi.nlm.nih.gov/11022792","citation_count":52,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"17682935","id":"PMC_17682935","title":"Identification and phylogenetic analysis of orf virus from goats in Taiwan.","date":"2007","source":"Virus genes","url":"https://pubmed.ncbi.nlm.nih.gov/17682935","citation_count":51,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"30718434","id":"PMC_30718434","title":"Magnesium-sensitive upstream ORF controls PRL phosphatase expression to mediate energy metabolism.","date":"2019","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/30718434","citation_count":48,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"29360145","id":"PMC_29360145","title":"Bile acids stimulate cholangiocyte fluid secretion by activation of transmembrane member 16A Cl- channels.","date":"2018","source":"Hepatology (Baltimore, Md.)","url":"https://pubmed.ncbi.nlm.nih.gov/29360145","citation_count":48,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"28452066","id":"PMC_28452066","title":"Inhibition of transmembrane member 16A calcium-activated chloride channels by natural flavonoids contributes to flavonoid anticancer effects.","date":"2017","source":"British journal of pharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/28452066","citation_count":47,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"9280386","id":"PMC_9280386","title":"The immune and inflammatory response to orf virus.","date":"1997","source":"Comparative immunology, microbiology and infectious diseases","url":"https://pubmed.ncbi.nlm.nih.gov/9280386","citation_count":46,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"17350223","id":"PMC_17350223","title":"A duplex PCR assay for simultaneous detection and differentiation of Capripoxvirus and Orf virus.","date":"2007","source":"Molecular and cellular probes","url":"https://pubmed.ncbi.nlm.nih.gov/17350223","citation_count":42,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"33468658","id":"PMC_33468658","title":"A short ORF-encoded transcriptional regulator.","date":"2021","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/33468658","citation_count":41,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"32471506","id":"PMC_32471506","title":"Developmental regulation of canonical and small ORF translation from mRNAs.","date":"2020","source":"Genome biology","url":"https://pubmed.ncbi.nlm.nih.gov/32471506","citation_count":39,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"31542928","id":"PMC_31542928","title":"MiR-16a Regulates Milk Fat Metabolism by Targeting Large Tumor Suppressor Kinase 1 (LATS1) in Bovine Mammary Epithelial Cells.","date":"2019","source":"Journal of agricultural and food chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/31542928","citation_count":39,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"23830075","id":"PMC_23830075","title":"An essential fifth coding ORF in the sobemoviruses.","date":"2013","source":"Virology","url":"https://pubmed.ncbi.nlm.nih.gov/23830075","citation_count":39,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"38431639","id":"PMC_38431639","title":"Widespread stable noncanonical peptides identified by integrated analyses of ribosome profiling and ORF features.","date":"2024","source":"Nature communications","url":"https://pubmed.ncbi.nlm.nih.gov/38431639","citation_count":39,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"25054082","id":"PMC_25054082","title":"Expression and detection of LINE-1 ORF-encoded proteins.","date":"2014","source":"Mobile genetic elements","url":"https://pubmed.ncbi.nlm.nih.gov/25054082","citation_count":35,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"32667280","id":"PMC_32667280","title":"A putative new SARS-CoV protein, 3c, encoded in an ORF overlapping ORF3a.","date":"2020","source":"The Journal of general virology","url":"https://pubmed.ncbi.nlm.nih.gov/32667280","citation_count":35,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"21346027","id":"PMC_21346027","title":"Characterization of immunostimulatory components of orf virus (parapoxvirus ovis).","date":"2011","source":"The Journal of general virology","url":"https://pubmed.ncbi.nlm.nih.gov/21346027","citation_count":35,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"11989824","id":"PMC_11989824","title":"Targeted disruption of the mouse gene encoding the V-ATPase accessory subunit Ac45.","date":"2002","source":"Molecular membrane biology","url":"https://pubmed.ncbi.nlm.nih.gov/11989824","citation_count":34,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"10614496","id":"PMC_10614496","title":"Immunomodulation by virulence proteins of the parapoxvirus orf virus.","date":"1999","source":"Veterinary immunology and immunopathology","url":"https://pubmed.ncbi.nlm.nih.gov/10614496","citation_count":34,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"12072264","id":"PMC_12072264","title":"Orf virus immuno-modulation and the host immune response.","date":"2002","source":"Veterinary immunology and immunopathology","url":"https://pubmed.ncbi.nlm.nih.gov/12072264","citation_count":34,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"36444690","id":"PMC_36444690","title":"Analysis of inhibitors of the anoctamin-1 chloride channel (transmembrane member 16A, TMEM16A) reveals indirect mechanisms involving alterations in calcium signalling.","date":"2022","source":"British journal of pharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/36444690","citation_count":33,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"24318514","id":"PMC_24318514","title":"Common variant of leucine-rich repeat-containing 16A (LRRC16A) gene is associated with gout susceptibility.","date":"2013","source":"Human cell","url":"https://pubmed.ncbi.nlm.nih.gov/24318514","citation_count":33,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"31742503","id":"PMC_31742503","title":"Human Infection with Orf Virus and Description of Its Whole Genome, France, 2017.","date":"2019","source":"Emerging infectious diseases","url":"https://pubmed.ncbi.nlm.nih.gov/31742503","citation_count":33,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"9519844","id":"PMC_9519844","title":"The pnk/pnl gene (ORF 86) of Autographa californica nucleopolyhedrovirus is a non-essential, immediate early gene.","date":"1998","source":"The Journal of general virology","url":"https://pubmed.ncbi.nlm.nih.gov/9519844","citation_count":33,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"12885901","id":"PMC_12885901","title":"Feline immunodeficiency virus ORF-Ais required for virus particle formation and virus infectivity.","date":"2003","source":"Journal of virology","url":"https://pubmed.ncbi.nlm.nih.gov/12885901","citation_count":33,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"10336633","id":"PMC_10336633","title":"Biosynthesis of the vacuolar H+-ATPase accessory subunit Ac45 in Xenopus pituitary.","date":"1999","source":"European journal of biochemistry","url":"https://pubmed.ncbi.nlm.nih.gov/10336633","citation_count":32,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"22044156","id":"PMC_22044156","title":"Novel insights into V-ATPase functioning: distinct roles for its accessory subunits ATP6AP1/Ac45 and ATP6AP2/(pro) renin receptor.","date":"2012","source":"Current protein & peptide science","url":"https://pubmed.ncbi.nlm.nih.gov/22044156","citation_count":31,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"10466798","id":"PMC_10466798","title":"Detection and characterization of proteins encoded by the second ORF of the M2 gene of pneumoviruses.","date":"1999","source":"The Journal of general virology","url":"https://pubmed.ncbi.nlm.nih.gov/10466798","citation_count":31,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"32446384","id":"PMC_32446384","title":"N6-methyladenosine modifications enhance enterovirus 71 ORF translation through METTL3 cytoplasmic distribution.","date":"2020","source":"Biochemical and biophysical research communications","url":"https://pubmed.ncbi.nlm.nih.gov/32446384","citation_count":30,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"11227191","id":"PMC_11227191","title":"Efficacy of a transmissible gastroenteritis coronavirus with an altered ORF-3 gene.","date":"2001","source":"Canadian journal of veterinary research = Revue canadienne de recherche veterinaire","url":"https://pubmed.ncbi.nlm.nih.gov/11227191","citation_count":27,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"12560570","id":"PMC_12560570","title":"Walleye dermal sarcoma virus Orf C is targeted to the mitochondria.","date":"2003","source":"The Journal of general virology","url":"https://pubmed.ncbi.nlm.nih.gov/12560570","citation_count":27,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"36366490","id":"PMC_36366490","title":"ORF-Interrupting Mutations in Monkeypox Virus Genomes from Washington and Ohio, 2022.","date":"2022","source":"Viruses","url":"https://pubmed.ncbi.nlm.nih.gov/36366490","citation_count":26,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"18657579","id":"PMC_18657579","title":"Accessory subunit Ac45 controls the V-ATPase in the regulated secretory pathway.","date":"2008","source":"Biochimica et biophysica acta","url":"https://pubmed.ncbi.nlm.nih.gov/18657579","citation_count":26,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"7831775","id":"PMC_7831775","title":"Identification and characterization of the orf virus type I topoisomerase.","date":"1995","source":"Virology","url":"https://pubmed.ncbi.nlm.nih.gov/7831775","citation_count":26,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"9739073","id":"PMC_9739073","title":"Intracellular trafficking of the vacuolar H+-ATPase accessory subunit Ac45.","date":"1998","source":"Journal of cell science","url":"https://pubmed.ncbi.nlm.nih.gov/9739073","citation_count":25,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"8988872","id":"PMC_8988872","title":"Cytokines and their inhibitors in orf virus infection.","date":"1996","source":"Veterinary immunology and immunopathology","url":"https://pubmed.ncbi.nlm.nih.gov/8988872","citation_count":25,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"29514099","id":"PMC_29514099","title":"Muscle-Specific Histone H3K36 Dimethyltransferase SET-18 Shortens Lifespan of Caenorhabditis elegans by Repressing daf-16a Expression.","date":"2018","source":"Cell reports","url":"https://pubmed.ncbi.nlm.nih.gov/29514099","citation_count":24,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"34240112","id":"PMC_34240112","title":"Understanding small ORF diversity through a comprehensive transcription feature classification.","date":"2021","source":"DNA research : an international journal for rapid publication of reports on genes and genomes","url":"https://pubmed.ncbi.nlm.nih.gov/34240112","citation_count":23,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"36473845","id":"PMC_36473845","title":"DAP5 enables main ORF translation on mRNAs with structured and uORF-containing 5' leaders.","date":"2022","source":"Nature communications","url":"https://pubmed.ncbi.nlm.nih.gov/36473845","citation_count":23,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"28571550","id":"PMC_28571550","title":"An Overwiev of ORF Virus Infection in Humans and Animals.","date":"2017","source":"Recent patents on anti-infective drug discovery","url":"https://pubmed.ncbi.nlm.nih.gov/28571550","citation_count":22,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"29968377","id":"PMC_29968377","title":"Transmembrane member 16A participates in hydrogen peroxide-induced apoptosis by facilitating mitochondria-dependent pathway in vascular smooth muscle cells.","date":"2018","source":"British journal of pharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/29968377","citation_count":22,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"23814477","id":"PMC_23814477","title":"Isolation and characterization of orf viruses from Korean black goats.","date":"2013","source":"Journal of veterinary science","url":"https://pubmed.ncbi.nlm.nih.gov/23814477","citation_count":21,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"8961292","id":"PMC_8961292","title":"Chromaffin granule membrane glycoprotein IV is identical with Ac45, a membrane-integral subunit of the granule's H(+)-ATPase.","date":"1996","source":"Neuroscience letters","url":"https://pubmed.ncbi.nlm.nih.gov/8961292","citation_count":21,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"11162816","id":"PMC_11162816","title":"Intracellular targeting of walleye dermal sarcoma virus Orf A (rv-cyclin).","date":"2001","source":"Virology","url":"https://pubmed.ncbi.nlm.nih.gov/11162816","citation_count":21,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"35656563","id":"PMC_35656563","title":"Exercise, Mitohormesis, and Mitochondrial ORF of the 12S rRNA Type-C (MOTS-c).","date":"2022","source":"Diabetes & metabolism journal","url":"https://pubmed.ncbi.nlm.nih.gov/35656563","citation_count":20,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"31852543","id":"PMC_31852543","title":"Role of HTLV-1 orf-I encoded proteins in viral transmission and persistence.","date":"2019","source":"Retrovirology","url":"https://pubmed.ncbi.nlm.nih.gov/31852543","citation_count":20,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"24633847","id":"PMC_24633847","title":"Detection of genetic variations in Orf virus isolates epidemic in Xinjiang China.","date":"2014","source":"Journal of basic microbiology","url":"https://pubmed.ncbi.nlm.nih.gov/24633847","citation_count":20,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"36723701","id":"PMC_36723701","title":"Recent advances in diagnostic approaches for orf virus.","date":"2023","source":"Applied microbiology and biotechnology","url":"https://pubmed.ncbi.nlm.nih.gov/36723701","citation_count":19,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"33866062","id":"PMC_33866062","title":"Orf virus ORFV112, ORFV117 and ORFV127 contribute to ORFV IA82 virulence in sheep.","date":"2021","source":"Veterinary microbiology","url":"https://pubmed.ncbi.nlm.nih.gov/33866062","citation_count":19,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"27995337","id":"PMC_27995337","title":"Functional characterization of recombinant major envelope protein (rB2L) of orf virus.","date":"2016","source":"Archives of virology","url":"https://pubmed.ncbi.nlm.nih.gov/27995337","citation_count":18,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"25694596","id":"PMC_25694596","title":"Functional analysis of the short isoform of orf virus protein OV20.0.","date":"2015","source":"Journal of virology","url":"https://pubmed.ncbi.nlm.nih.gov/25694596","citation_count":18,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"17600074","id":"PMC_17600074","title":"Genetic and physiological characterization of the Borrelia burgdorferi ORF BB0374-pfs-metK-luxS operon.","date":"2007","source":"Microbiology (Reading, England)","url":"https://pubmed.ncbi.nlm.nih.gov/17600074","citation_count":18,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"27178401","id":"PMC_27178401","title":"Molecular characterization of Orf virus in goats in Gabon, Central Africa.","date":"2016","source":"Virology journal","url":"https://pubmed.ncbi.nlm.nih.gov/27178401","citation_count":18,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"25796398","id":"PMC_25796398","title":"Identification and molecular characterization of Orf virus in Argentina.","date":"2015","source":"Virus genes","url":"https://pubmed.ncbi.nlm.nih.gov/25796398","citation_count":18,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"17542963","id":"PMC_17542963","title":"Isolation and characterization of an Indian ORF virus from goats.","date":"2007","source":"Zoonoses and public health","url":"https://pubmed.ncbi.nlm.nih.gov/17542963","citation_count":18,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"34287041","id":"PMC_34287041","title":"Orf Virus ORF120 Protein Positively Regulates the NF-κB Pathway by Interacting with G3BP1.","date":"2021","source":"Journal of virology","url":"https://pubmed.ncbi.nlm.nih.gov/34287041","citation_count":17,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"30651363","id":"PMC_30651363","title":"Adenosine Deaminase Acting on RNA 1 Associates with Orf Virus OV20.0 and Enhances Viral Replication.","date":"2019","source":"Journal of virology","url":"https://pubmed.ncbi.nlm.nih.gov/30651363","citation_count":17,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"27283114","id":"PMC_27283114","title":"Attenuation and protection efficacy of ORF C gene-deleted recombinant of infectious laryngotracheitis virus.","date":"2016","source":"The Journal of general virology","url":"https://pubmed.ncbi.nlm.nih.gov/27283114","citation_count":17,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"9335578","id":"PMC_9335578","title":"Roles for lambda Orf and Escherichia coli RecO, RecR and RecF in lambda recombination.","date":"1997","source":"Genetics","url":"https://pubmed.ncbi.nlm.nih.gov/9335578","citation_count":17,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"15351483","id":"PMC_15351483","title":"Heparin binding activity of orf virus F1L protein.","date":"2004","source":"Virus research","url":"https://pubmed.ncbi.nlm.nih.gov/15351483","citation_count":17,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"38056893","id":"PMC_38056893","title":"iPSC-derived natural killer cells expressing the FcγR fusion CD64/16A can be armed with antibodies for multitumor antigen targeting.","date":"2023","source":"Journal for immunotherapy of cancer","url":"https://pubmed.ncbi.nlm.nih.gov/38056893","citation_count":16,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"38580077","id":"PMC_38580077","title":"An Inner Mitochondrial Membrane Microprotein from the SLC35A4 Upstream ORF Regulates Cellular Metabolism.","date":"2024","source":"Journal of molecular biology","url":"https://pubmed.ncbi.nlm.nih.gov/38580077","citation_count":16,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"38448650","id":"PMC_38448650","title":"The rapid proximity labeling system PhastID identifies ATP6AP1 as an unconventional GEF for Rheb.","date":"2024","source":"Cell research","url":"https://pubmed.ncbi.nlm.nih.gov/38448650","citation_count":15,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"25952706","id":"PMC_25952706","title":"Ac45 silencing mediated by AAV-sh-Ac45-RNAi prevents both bone loss and inflammation caused by periodontitis.","date":"2015","source":"Journal of clinical periodontology","url":"https://pubmed.ncbi.nlm.nih.gov/25952706","citation_count":15,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"20702583","id":"PMC_20702583","title":"V-ATPase-mediated granular acidification is regulated by the V-ATPase accessory subunit Ac45 in POMC-producing cells.","date":"2010","source":"Molecular biology of the cell","url":"https://pubmed.ncbi.nlm.nih.gov/20702583","citation_count":15,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"36574498","id":"PMC_36574498","title":"Natural Compound Allicin Containing Thiosulfinate Moieties as Transmembrane Protein 16A (TMEM16A) Ion Channel Inhibitor for Food Adjuvant Therapy of Lung Cancer.","date":"2022","source":"Journal of agricultural and food chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/36574498","citation_count":15,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"26645035","id":"PMC_26645035","title":"Isolation and phylogenetic analysis of caprine Orf virus in Malaysia.","date":"2015","source":"Virusdisease","url":"https://pubmed.ncbi.nlm.nih.gov/26645035","citation_count":15,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"24237155","id":"PMC_24237155","title":"Functional evaluation of the role of C-type lectin domain family 16A at the chromosome 16p13 locus.","date":"2014","source":"Clinical and experimental immunology","url":"https://pubmed.ncbi.nlm.nih.gov/24237155","citation_count":14,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"27795413","id":"PMC_27795413","title":"Ankyrin Repeat Proteins of Orf Virus Influence the Cellular Hypoxia Response Pathway.","date":"2016","source":"Journal of virology","url":"https://pubmed.ncbi.nlm.nih.gov/27795413","citation_count":14,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"11962638","id":"PMC_11962638","title":"RAPD isolation of a Y chromosome specific ORF in a dioecious plant, Silene latifolia.","date":"2002","source":"Genome","url":"https://pubmed.ncbi.nlm.nih.gov/11962638","citation_count":14,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"31510805","id":"PMC_31510805","title":"iNK-CD64/16A cells: a promising approach for ADCC?","date":"2019","source":"Expert opinion on biological therapy","url":"https://pubmed.ncbi.nlm.nih.gov/31510805","citation_count":13,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"33506118","id":"PMC_33506118","title":"Biochemical and molecular study on serum miRNA-16a and miRNA- 451 as neonatal sepsis biomarkers.","date":"2021","source":"Biochemistry and biophysics reports","url":"https://pubmed.ncbi.nlm.nih.gov/33506118","citation_count":13,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"22736765","id":"PMC_22736765","title":"Identification of domains within the V-ATPase accessory subunit Ac45 involved in V-ATPase transport and Ca2+-dependent exocytosis.","date":"2012","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/22736765","citation_count":13,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"25176590","id":"PMC_25176590","title":"Major cleavage-dependent epitopes for linear IgA bullous dermatosis are formed at the boundary between the non-collagenous 16A and collagenous 15 domains of BP180.","date":"2014","source":"Journal of dermatological science","url":"https://pubmed.ncbi.nlm.nih.gov/25176590","citation_count":13,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"11952786","id":"PMC_11952786","title":"The fate of newly synthesized V-ATPase accessory subunit Ac45 in the secretory pathway.","date":"2002","source":"European journal of biochemistry","url":"https://pubmed.ncbi.nlm.nih.gov/11952786","citation_count":13,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"32353859","id":"PMC_32353859","title":"A SARS-CoV-2 protein interaction map reveals targets for drug repurposing.","date":"2020","source":"Nature","url":"https://pubmed.ncbi.nlm.nih.gov/32353859","citation_count":3411,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"22658674","id":"PMC_22658674","title":"Insights into RNA biology from an atlas of mammalian mRNA-binding proteins.","date":"2012","source":"Cell","url":"https://pubmed.ncbi.nlm.nih.gov/22658674","citation_count":1718,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"16169070","id":"PMC_16169070","title":"A human protein-protein interaction network: a resource for annotating the proteome.","date":"2005","source":"Cell","url":"https://pubmed.ncbi.nlm.nih.gov/16169070","citation_count":1704,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"12477932","id":"PMC_12477932","title":"Generation and initial analysis of more than 15,000 full-length human and mouse cDNA sequences.","date":"2002","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/12477932","citation_count":1479,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"22053050","id":"PMC_22053050","title":"mTORC1 senses lysosomal amino acids through an inside-out mechanism that requires the vacuolar H(+)-ATPase.","date":"2011","source":"Science (New York, N.Y.)","url":"https://pubmed.ncbi.nlm.nih.gov/22053050","citation_count":1323,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"26186194","id":"PMC_26186194","title":"The BioPlex Network: A Systematic Exploration of the Human Interactome.","date":"2015","source":"Cell","url":"https://pubmed.ncbi.nlm.nih.gov/26186194","citation_count":1118,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"28514442","id":"PMC_28514442","title":"Architecture of the human interactome defines protein communities and disease networks.","date":"2017","source":"Nature","url":"https://pubmed.ncbi.nlm.nih.gov/28514442","citation_count":1085,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"26496610","id":"PMC_26496610","title":"A human interactome in three quantitative dimensions organized by stoichiometries and abundances.","date":"2015","source":"Cell","url":"https://pubmed.ncbi.nlm.nih.gov/26496610","citation_count":1015,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"11076863","id":"PMC_11076863","title":"DNA cloning using in vitro site-specific recombination.","date":"2000","source":"Genome research","url":"https://pubmed.ncbi.nlm.nih.gov/11076863","citation_count":815,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"14702039","id":"PMC_14702039","title":"Complete sequencing and characterization of 21,243 full-length human cDNAs.","date":"2003","source":"Nature genetics","url":"https://pubmed.ncbi.nlm.nih.gov/14702039","citation_count":754,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"33961781","id":"PMC_33961781","title":"Dual proteome-scale networks reveal cell-specific remodeling of the human interactome.","date":"2021","source":"Cell","url":"https://pubmed.ncbi.nlm.nih.gov/33961781","citation_count":705,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"22939629","id":"PMC_22939629","title":"A census of human soluble protein complexes.","date":"2012","source":"Cell","url":"https://pubmed.ncbi.nlm.nih.gov/22939629","citation_count":689,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"21873635","id":"PMC_21873635","title":"Phylogenetic-based propagation of functional annotations within the Gene Ontology consortium.","date":"2011","source":"Briefings in bioinformatics","url":"https://pubmed.ncbi.nlm.nih.gov/21873635","citation_count":656,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"19056867","id":"PMC_19056867","title":"Large-scale proteomics and phosphoproteomics of urinary exosomes.","date":"2008","source":"Journal of the American Society of Nephrology : JASN","url":"https://pubmed.ncbi.nlm.nih.gov/19056867","citation_count":607,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"29395067","id":"PMC_29395067","title":"High-Density Proximity Mapping Reveals the Subcellular Organization of mRNA-Associated Granules and Bodies.","date":"2018","source":"Molecular cell","url":"https://pubmed.ncbi.nlm.nih.gov/29395067","citation_count":580,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"33060197","id":"PMC_33060197","title":"Comparative host-coronavirus protein interaction networks reveal pan-viral disease mechanisms.","date":"2020","source":"Science (New York, N.Y.)","url":"https://pubmed.ncbi.nlm.nih.gov/33060197","citation_count":564,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"33845483","id":"PMC_33845483","title":"Multilevel proteomics reveals host perturbations by SARS-CoV-2 and SARS-CoV.","date":"2021","source":"Nature","url":"https://pubmed.ncbi.nlm.nih.gov/33845483","citation_count":532,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"9442887","id":"PMC_9442887","title":"Structure, function and regulation of the vacuolar (H+)-ATPase.","date":"1997","source":"Annual review of cell and developmental biology","url":"https://pubmed.ncbi.nlm.nih.gov/9442887","citation_count":488,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"15489334","id":"PMC_15489334","title":"The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC).","date":"2004","source":"Genome research","url":"https://pubmed.ncbi.nlm.nih.gov/15489334","citation_count":438,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"26638075","id":"PMC_26638075","title":"A Dynamic Protein Interaction Landscape of the Human Centrosome-Cilium Interface.","date":"2015","source":"Cell","url":"https://pubmed.ncbi.nlm.nih.gov/26638075","citation_count":433,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"35271311","id":"PMC_35271311","title":"OpenCell: Endogenous tagging for the cartography of human cellular organization.","date":"2022","source":"Science (New York, N.Y.)","url":"https://pubmed.ncbi.nlm.nih.gov/35271311","citation_count":432,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"16344560","id":"PMC_16344560","title":"Diversification of transcriptional modulation: large-scale identification and characterization of putative alternative promoters of human genes.","date":"2005","source":"Genome research","url":"https://pubmed.ncbi.nlm.nih.gov/16344560","citation_count":409,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"10221984","id":"PMC_10221984","title":"Vacuolar and plasma membrane proton-adenosinetriphosphatases.","date":"1999","source":"Physiological reviews","url":"https://pubmed.ncbi.nlm.nih.gov/10221984","citation_count":348,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"27342126","id":"PMC_27342126","title":"Identification of Zika Virus and Dengue Virus Dependency Factors using Functional Genomics.","date":"2016","source":"Cell reports","url":"https://pubmed.ncbi.nlm.nih.gov/27342126","citation_count":306,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"25713363","id":"PMC_25713363","title":"Mutations in early follicular lymphoma progenitors are associated with suppressed antigen presentation.","date":"2015","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/25713363","citation_count":298,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"32322062","id":"PMC_32322062","title":"The gluconeogenic enzyme PCK1 phosphorylates INSIG1/2 for lipogenesis.","date":"2020","source":"Nature","url":"https://pubmed.ncbi.nlm.nih.gov/32322062","citation_count":292,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"10224039","id":"PMC_10224039","title":"Structure and properties of the vacuolar (H+)-ATPases.","date":"1999","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/10224039","citation_count":252,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"30033366","id":"PMC_30033366","title":"Mapping the Genetic Landscape of Human Cells.","date":"2018","source":"Cell","url":"https://pubmed.ncbi.nlm.nih.gov/30033366","citation_count":225,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"22810585","id":"PMC_22810585","title":"Viral immune modulators perturb the human molecular network by common and unique strategies.","date":"2012","source":"Nature","url":"https://pubmed.ncbi.nlm.nih.gov/22810585","citation_count":219,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"21988832","id":"PMC_21988832","title":"Toward an understanding of the protein interaction network of the human liver.","date":"2011","source":"Molecular systems biology","url":"https://pubmed.ncbi.nlm.nih.gov/21988832","citation_count":207,"is_preprint":false,"source_track":"gene2pubmed"}],"cost":{"stage1":{"model":"claude-sonnet-4-6","input_tokens":46189,"output_tokens":4391,"usd":0.102216},"stage2":{"model":"claude-opus-4-6","input_tokens":7833,"output_tokens":3124,"usd":0.175898},"total_usd":0.599286,"stage1_batch_id":"msgbatch_01TqNM6p6FsoMBT2jzQTwKBr","stage2_batch_id":"msgbatch_01Ya473eco8sTHbvRymQaU8o","note":"batch pricing = 50% of standard","round2_stage1":{"model":"claude-sonnet-4-6","input_tokens":58364,"output_tokens":5371,"usd":0.127829},"round2_rules_fired":"R3","round2_stage2":{"model":"claude-opus-4-6","input_tokens":8359,"output_tokens":3484,"usd":0.193343}},"stage1_raw":"```json\n{\n  \"discoveries\": [\n    {\n      \"year\": 2016,\n      \"finding\": \"ATP6AP1 (Ac45) is the functional ortholog of the yeast V-ATPase assembly factor Voa1. Processed wild-type Ac45, but not its disease-associated missense mutants, restored V-ATPase-dependent growth in Voa1 mutant yeast. ATP6AP1 loss-of-function mutations in patients cause immunodeficiency with hypogammaglobulinemia, hepatopathy, and neurocognitive abnormalities linked to tissue-specific V-ATPase assembly defects.\",\n      \"method\": \"Yeast complementation assay (Voa1 mutant rescue), patient missense mutant functional analysis, homology detection at sequence profile level, Western blot showing tissue-specific Ac45 isoforms (40 kDa in brain, 62 kDa in liver, 50 kDa in B-cells)\",\n      \"journal\": \"Nature communications\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 — yeast complementation reconstitution, multiple orthogonal methods, patient mutations tested, single strong study\",\n      \"pmids\": [\"27231034\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2018,\n      \"finding\": \"Loss-of-function somatic mutations in ATP6AP1 are clonal oncogenic drivers of granular cell tumors (GCTs). Silencing of ATP6AP1 in vitro impairs vesicle acidification, redistributes endosomal compartments, causes accumulation of intracytoplasmic granules, and confers oncogenic properties, recapitulating the cardinal phenotypic features of GCTs.\",\n      \"method\": \"Whole-exome sequencing, targeted sequencing, siRNA knockdown with vesicle acidification assays, endosomal redistribution imaging, oncogenic property assays\",\n      \"journal\": \"Nature communications\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 — multiple orthogonal methods (sequencing + functional KD + phenotypic readouts), replicated across ATP6AP1 and ATP6AP2\",\n      \"pmids\": [\"30166553\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2022,\n      \"finding\": \"SARS-CoV-2 NSP6 directly interacts with ATP6AP1, a V-ATPase proton pump component, and inhibits its cleavage-mediated activation, thereby impairing lysosome acidification and autophagic flux, leading to NLRP3/ASC-dependent caspase-1 activation, IL-1β/18 maturation, and pyroptosis in lung epithelial cells. The L37F NSP6 variant showed reduced ATP6AP1 binding and weakened lysosome acidification impairment.\",\n      \"method\": \"Co-immunoprecipitation (NSP6–ATP6AP1 interaction), overexpression and knockdown functional assays, lysosome acidification assays, autophagic flux assays, caspase-1 activation readouts, mutagenesis (L37F variant binding), live SARS-CoV-2 infection model\",\n      \"journal\": \"Cell death and differentiation\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 — direct binding demonstrated by Co-IP, mutagenesis of binding interface, multiple orthogonal functional readouts in same study\",\n      \"pmids\": [\"34997207\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2024,\n      \"finding\": \"ATP6AP1 functions as an unconventional guanine nucleotide exchange factor (GEF) for Rheb, the direct activator of mTORC1. ATP6AP1 dynamically interacts with Rheb through its last 12 amino acids and utilizes a tri-aspartate motif in its highly conserved C-tail to enhance Rheb GTP loading, thereby integrating nutrient/insulin signals into mTORC1 activation. Targeting the ATP6AP1 C-tail blocks Rheb activation and inhibits cancer cell proliferation and migration.\",\n      \"method\": \"PhastID proximity labeling, Co-immunoprecipitation, in vitro GEF activity assay (Rheb GTP loading), C-tail deletion/mutagenesis (tri-aspartate motif), cancer cell proliferation and migration assays\",\n      \"journal\": \"Cell research\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — in vitro reconstitution of GEF activity, mutagenesis of catalytic motif, proximity labeling, and functional cellular assays in same study\",\n      \"pmids\": [\"38448650\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2012,\n      \"finding\": \"ATP6AP1 (Ac45) is essential for osteoclast-mediated extracellular acidification and bone resorption. Ac45 knockdown osteoclasts formed normal actin rings but had severely impaired extracellular acidification, bone resorption, lysosomal trafficking to the ruffled border, and cathepsin K exocytosis. The impaired exocytosis was specific to Ac45 deficiency and not a general V-ATPase consequence. Ac45 appears to guide lysosomal trafficking potentially through interaction with Rab7.\",\n      \"method\": \"siRNA knockdown, extracellular acidification assay, bone resorption assay, lysosomal trafficking imaging, cathepsin K exocytosis assay, osteoclast differentiation assay, ERK phosphorylation analysis\",\n      \"journal\": \"Journal of bone and mineral research\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — clean KD with multiple defined cellular phenotype readouts, orthogonal functional assays in same study\",\n      \"pmids\": [\"22467241\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2010,\n      \"finding\": \"V-ATPase accessory subunit Ac45 (ATP6AP1) regulates V-ATPase-mediated granular acidification in POMC-producing neuroendocrine cells. Transgenic overexpression of Ac45 in Xenopus melanotrope cells significantly increased granular acidification, reduced sensitivity to a V-ATPase-specific inhibitor, enhanced early POMC processing by PC1, and altered proPC2 maturation. Ac45 is established as the first identified regulator of the V-ATPase proton pump.\",\n      \"method\": \"Transgenic overexpression in Xenopus melanotrope cells, granular acidification assay, V-ATPase inhibitor sensitivity assay, prohormone processing analysis (POMC, PC1, PC2), biochemical fractionation\",\n      \"journal\": \"Molecular biology of the cell\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 — in vivo transgenic model with multiple orthogonal mechanistic readouts\",\n      \"pmids\": [\"20702583\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2008,\n      \"finding\": \"Ac45 (ATP6AP1) guides the V-ATPase through the regulated secretory pathway in neuroendocrine cells, causing V-ATPase accumulation at the plasma membrane, increased secretory granule abundance, plasma membrane protrusions, and enhanced Ca2+-dependent secretion efficiency when transgenically overexpressed in Xenopus melanotrope cells.\",\n      \"method\": \"Transgenic expression in Xenopus intermediate pituitary melanotrope cells, immunoelectron microscopy, Ca2+-dependent secretion assay, Western blot analysis of V-ATPase subunit levels\",\n      \"journal\": \"Biochimica et biophysica acta\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 — transgenic model with direct subcellular localization and functional secretion readouts\",\n      \"pmids\": [\"18657579\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2012,\n      \"finding\": \"Ac45 (ATP6AP1) interacts with the V0-sector of the V-ATPase complex and regulates intragranular pH and Ca2+-dependent exocytotic membrane fusion in neuroendocrine/secretory cells. The accessory subunit functions as a V-ATPase regulator in the neuroendocrine secretory pathway.\",\n      \"method\": \"Co-immunoprecipitation, functional secretion assays, review synthesizing prior biochemical and cell biological data\",\n      \"journal\": \"Current protein & peptide science\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 3 — review paper synthesizing Co-IP data and prior functional studies; interaction established in prior primary literature\",\n      \"pmids\": [\"22044156\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2008,\n      \"finding\": \"Furin cleaves Ac45 (ATP6AP1) at a specific site ex vivo, and this cleavage is important for regulated secretion and intragranular acidification in pancreatic beta cells. Downregulation of either furin or Ac45 in insulinoma cells reduced regulated secretion and proinsulin II processing.\",\n      \"method\": \"Ex vivo cleavage assay (furin + Ac45 substrate), siRNA knockdown of furin or Ac45 in betaTC3 cells, DAMP acidification assay in furin KO mouse beta cells, cleavage site determination\",\n      \"journal\": \"Proceedings of the National Academy of Sciences of the United States of America\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 — in vitro/ex vivo cleavage assay, genetic KO mouse model, siRNA knockdown, and acidification assay in same study\",\n      \"pmids\": [\"18713856\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2002,\n      \"finding\": \"Ac45 (ATP6AP1) is essential for early embryonic development: targeted disruption of the Ac45 gene in mouse embryonic stem cells resulted in failure of normal blastocyst development, consistent with an essential role for V-ATPase in early embryogenesis.\",\n      \"method\": \"Gene targeting/knockout in mouse embryonic stem cells, blastocyst injection, chimera generation\",\n      \"journal\": \"Molecular membrane biology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — clean KO with developmental phenotype, but limited mechanistic follow-up beyond essentiality\",\n      \"pmids\": [\"11989824\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2002,\n      \"finding\": \"The Ac45 (ATP6AP1) protein undergoes N-linked glycosylation to ~62 kDa, followed by cleavage in the early secretory pathway (half-life of intact form ~4–6 h) to yield a C-terminal ~42–44 kDa fragment and a ~22 kDa N-terminal fragment. Cleavage requires proper Ac45 folding (inhibited by tunicamycin), occurs before the medial Golgi, and may be linked to V-ATPase activation.\",\n      \"method\": \"Pulse-chase biosynthetic labeling, endoglycosidase H sensitivity assay, tunicamycin/brefeldin A/monensin pharmacological inhibitors, deglycosylation, subcellular fractionation\",\n      \"journal\": \"European journal of biochemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — multiple orthogonal biochemical methods defining cleavage mechanism and pathway\",\n      \"pmids\": [\"11952786\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1999,\n      \"finding\": \"Xenopus Ac45 (ATP6AP1 ortholog) is synthesized as an N-glycosylated ~60 kDa precursor in neuroendocrine melanotrope cells and is proteolytically cleaved to a ~40 kDa product. The protein is predominantly expressed in neuroendocrine tissues and associates with V-ATPase to assist in secretory granule acidification.\",\n      \"method\": \"cDNA cloning, Western blot with deglycosylation, biosynthetic labeling, immunocytochemistry\",\n      \"journal\": \"European journal of biochemistry\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — multiple biochemical methods in Xenopus ortholog model, localization with functional inference\",\n      \"pmids\": [\"10336633\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1998,\n      \"finding\": \"The cytoplasmic tail of Ac45 (ATP6AP1) contains an autonomous internalization signal that mediates rapid endocytosis from the cell surface to a juxtanuclear vacuolar compartment. Multiple sites in the membrane-distal region of the 26-residue cytoplasmic tail are responsible for internalization, distinct from canonical tyrosine- or di-leucine-based sorting motifs.\",\n      \"method\": \"Steady-state immunolabeling, antibody internalization experiments, transfection of truncation mutants and chimeric Tac constructs, immunolocalization\",\n      \"journal\": \"Journal of cell science\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 — direct localization experiments with mutagenesis and chimeric protein assays defining functional domain\",\n      \"pmids\": [\"9739073\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2012,\n      \"finding\": \"Proteolytic processing of Ac45 (ATP6AP1) is required for its function: cleaved-Ac45 is efficiently transported through the secretory pathway and accumulates the V-ATPase at the plasma membrane, reducing dopaminergic inhibition of Ca2+-dependent peptide secretion. The N-terminal domain of intact-Ac45 retains it in the ER. The C-tail of cleaved-Ac45 is required for V-ATPase recruitment into the secretory pathway and for Ca2+-dependent regulated exocytosis, but not for plasma membrane targeting.\",\n      \"method\": \"Transgenic Xenopus melanotrope cell expression of deletion mutants, immunofluorescence, V-ATPase localization assay, Ca2+-dependent secretion assay, dopaminergic inhibition assay\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 — domain mapping with multiple deletion mutants in vivo in transgenic model, multiple orthogonal functional readouts\",\n      \"pmids\": [\"22736765\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1996,\n      \"finding\": \"Chromaffin granule glycoprotein IV is identical to Ac45 (ATP6AP1) and is a membrane-integral subunit of the granule H+-ATPase (V-ATPase). Mature Ac45/glycoprotein IV is derived from a larger precursor by removal of a 246-amino acid N-terminal sequence, yielding an ~29 kDa polypeptide, confirmed by Blue Native electrophoresis showing it as a component of the V-ATPase membrane sector.\",\n      \"method\": \"Protein purification (Triton X-114 fractionation, lectin affinity chromatography), antiserum cross-reactivity, amino acid sequencing, enzymatic deglycosylation, Blue Native electrophoresis\",\n      \"journal\": \"Neuroscience letters\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — direct protein identification and complex membership established by purification, sequencing, and native gel electrophoresis\",\n      \"pmids\": [\"8961292\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2015,\n      \"finding\": \"AAV-mediated siRNA knockdown of Ac45 (ATP6AP1) in a periodontitis mouse model impaired osteoclast-mediated extracellular acidification and bone resorption in vivo, protecting against bone erosion by >85% and attenuating gingival inflammation and pro-inflammatory cytokine expression.\",\n      \"method\": \"AAV-mediated RNAi in mouse periodontitis model, histological analysis, immunohistochemistry, ELISA, qRT-PCR, in vitro acidification assay\",\n      \"journal\": \"Journal of clinical periodontology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — in vivo KD with defined bone resorption and inflammation phenotype; extends osteoclast findings from prior work\",\n      \"pmids\": [\"25952706\"],\n      \"is_preprint\": false\n    }\n  ],\n  \"current_model\": \"ATP6AP1 (Ac45) is a type I transmembrane accessory subunit and assembly factor of the V-ATPase that, upon furin-mediated proteolytic cleavage in the early secretory pathway, associates with the V0 membrane sector to regulate organelle and granule acidification, guide V-ATPase trafficking through the regulated secretory pathway to promote Ca2+-dependent exocytosis, direct lysosomal trafficking in osteoclasts, and, at the lysosomal surface, acts as an unconventional GEF for Rheb to activate mTORC1; its inhibition by SARS-CoV-2 NSP6 impairs lysosomal acidification and autophagic flux to trigger NLRP3-dependent pyroptosis.\"\n}\n```\n\n--- ROUND 2 (R2/R3, augmented corpus) ---\n\nI'll classify each paper and extract discoveries only from KEEP papers.\n\n**Classification summary:**\n- Papers about ATP6AP1/Ac45 (the V-ATPase accessory subunit): KEEP\n- Papers about \"ORF virus\" (parapoxvirus): EXCLUDE (alias collision)\n- Papers about generic ORF/open reading frame methodology: EXCLUDE\n- Papers about TMEM16A, LRRC16A, miRNA-16a, etc.: EXCLUDE (different genes)\n- Broad proteomics/interactome papers that happen to include ATP6AP1 as one of thousands of proteins: EXCLUDE (no mechanistic finding about ATP6AP1 specifically)\n- SARS-CoV-2 NSP6 targeting ATP6AP1: KEEP\n- ATP6AP1 as GEF for Rheb: KEEP\n\n**KEPT papers:**\n- PMID:34997207 (NSP6/ATP6AP1/pyroptosis)\n- PMID:27231034 (ATP6AP1 deficiency/Ac45/V-ATPase assembly)\n- PMID:30166553 (GCT mutations in ATP6AP1)\n- PMID:22467241 (Ac45 in osteoclasts)\n- PMID:18713856 (furin cleaves Ac45)\n- PMID:18657579 (Ac45 controls V-ATPase in secretory pathway)\n- PMID:22044156 (review: Ac45/ATP6AP2 roles)\n- PMID:11989824 (Ac45 gene knockout)\n- PMID:10336633 (Xenopus Ac45 biosynthesis)\n- PMID:9739073 (Ac45 intracellular trafficking)\n- PMID:11952786 (Ac45 fate in secretory pathway)\n- PMID:8961292 (Ac45 = chromaffin granule glycoprotein IV)\n- PMID:20702583 (Ac45 regulates granular acidification)\n- PMID:22736765 (Ac45 domains for V-ATPase transport/exocytosis)\n- PMID:25952706 (AAV-sh-Ac45 in periodontitis)\n- PMID:38448650 (ATP6AP1 as GEF for Rheb)\n- PMID:22053050 (v-ATPase/mTORC1 - mechanistic, but about v-ATPase generally, not ATP6AP1 specifically - borderline; ATP6AP1 not specifically studied)\n- PMID:25713363 (follicular lymphoma - ATP6AP1 mentioned in mutations context but no mechanism)\n\n```json\n{\n  \"discoveries\": [\n    {\n      \"year\": 1996,\n      \"finding\": \"ATP6AP1 (Ac45) was identified as chromaffin granule membrane glycoprotein IV and confirmed to be a membrane-integral subunit of the granule V-ATPase. Amino acid sequencing showed that Ac45/glycoprotein IV is derived from a larger precursor by removal of a 246-amino acid N-terminal sequence, yielding a mature ~29 kDa polypeptide. Blue Native electrophoresis confirmed its incorporation into the membrane sector (V0) of the V-ATPase.\",\n      \"method\": \"Membrane fractionation, lectin affinity chromatography, amino acid sequencing, enzymatic deglycosylation, Blue Native electrophoresis\",\n      \"journal\": \"Neuroscience letters\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — direct biochemical purification and sequencing with structural confirmation by native electrophoresis\",\n      \"pmids\": [\"8961292\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1998,\n      \"finding\": \"ATP6AP1 (Ac45) localizes to the plasma membrane and a juxtanuclear vacuolar compartment, and is rapidly retrieved from the cell surface via endocytosis. The 26-residue cytoplasmic tail of Ac45 contains an autonomous internalization signal distinct from canonical tyrosine- or di-leucine-based motifs; multiple sites in the membrane-distal region of the tail are required for internalization.\",\n      \"method\": \"Steady-state immunolabeling, antibody internalization experiments, expression of carboxy-terminally truncated Ac45 mutants, immunolocalization in transfected CV-1 fibroblasts\",\n      \"journal\": \"Journal of cell science\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — direct localization experiments with functional mutagenesis of sorting signal in multiple deletion constructs\",\n      \"pmids\": [\"9739073\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1999,\n      \"finding\": \"Xenopus ATP6AP1 (Ac45) is synthesized as an N-glycosylated ~60 kDa precursor that is intracellularly cleaved to a ~40 kDa C-terminal product, with the processed form predominating in neuroendocrine tissues. Ac45 is highly expressed in biosynthetically active melanotrope cells of the intermediate pituitary, consistent with a role in acidification of neuroendocrine secretory granules.\",\n      \"method\": \"Western blot, biosynthetic labeling, deglycosylation, immunocytochemistry in Xenopus pituitary\",\n      \"journal\": \"European journal of biochemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — biosynthetic studies with deglycosylation and direct tissue immunolocalization; replicated in neuroendocrine context\",\n      \"pmids\": [\"10336633\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2002,\n      \"finding\": \"Targeted disruption of the Ac45 (ATP6AP1) gene in mouse embryonic stem cells produced Ac45 null mutant (−/Y) ES cells. Injection into blastocysts led to severely impaired development, with only one low-chimeric female born that died at 6 weeks; no late abortions were detected. Results indicate that Ac45 null ES cells disrupt normal blastocyst development, consistent with an essential role for V-ATPase in early embryogenesis.\",\n      \"method\": \"Gene targeting by homologous recombination in ES cells, blastocyst injection, chimera analysis\",\n      \"journal\": \"Molecular membrane biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — clean genetic knockout with defined developmental phenotype\",\n      \"pmids\": [\"11989824\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2002,\n      \"finding\": \"Newly synthesized ATP6AP1 (Ac45) is N-glycosylated to ~62 kDa and ~64 kDa forms; glycan trimming produces ~61 and ~63 kDa forms that are cleaved to a C-terminal ~42–44 kDa fragment and a previously undetected ~22 kDa N-terminal fragment. Cleavage occurs early in the secretory pathway (brefeldin A- and monensin-insensitive), has a half-life of 4–6 h, and requires proper N-glycosylation-dependent folding. The N-terminal fragment is rapidly degraded in a non-lysosomal, brefeldin A-sensitive compartment.\",\n      \"method\": \"Biosynthetic pulse-chase labeling, pharmacological inhibitors (brefeldin A, monensin, tunicamycin), endoglycosidase H resistance assay in neuroendocrine cells\",\n      \"journal\": \"European journal of biochemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1/2 — detailed biosynthetic analysis with orthogonal pharmacological dissection of cleavage site and kinetics\",\n      \"pmids\": [\"11952786\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2008,\n      \"finding\": \"Transgenic overexpression of ATP6AP1 (Ac45) specifically in Xenopus melanotrope cells caused accumulation of the V-ATPase at the plasma membrane, increased abundance of secretory granules, plasma membrane protrusions, and enhanced Ca2+-dependent peptide secretion. Ac45 transgene did not alter levels of prohormone POMC or V-ATPase subunits, indicating Ac45 guides the V-ATPase through the secretory pathway to regulate Ca2+-dependent exocytosis.\",\n      \"method\": \"Transgenic Xenopus melanotrope cell model, immunofluorescence, electron microscopy, Ca2+-dependent secretion assay\",\n      \"journal\": \"Biochimica et biophysica acta\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — in vivo transgenic gain-of-function with multiple orthogonal readouts (localization, ultrastructure, secretion)\",\n      \"pmids\": [\"18657579\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2008,\n      \"finding\": \"Furin was identified as a proprotein convertase that cleaves ATP6AP1 (Ac45) in the endocrine pancreas. Furin-deficient beta cells showed significantly decreased granule acidification. Ac45 is highly expressed in islets of Langerhans, and furin cleaves Ac45 ex vivo at a defined site. Knockdown of either furin or Ac45 in insulinoma betaTC3 cells similarly reduced regulated secretion and proinsulin II processing, establishing furin as the writer of Ac45 cleavage-mediated activation.\",\n      \"method\": \"Conditional furin knockout mice (Pdx1-Cre/loxP), DAMP acidification assay, ex vivo cleavage assay, siRNA knockdown in insulinoma cells, secretion and processing assays\",\n      \"journal\": \"Proceedings of the National Academy of Sciences of the United States of America\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1/2 — in vivo knockout plus ex vivo cleavage assay plus RNAi validation with multiple functional readouts\",\n      \"pmids\": [\"18713856\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2010,\n      \"finding\": \"Transgenic manipulation of ATP6AP1 (Ac45) levels in Xenopus melanotrope cells demonstrated that Ac45 directly regulates V-ATPase-mediated granular acidification. Elevated Ac45 significantly increased granular acidification, reduced sensitivity to the V-ATPase inhibitor bafilomycin A1, enhanced early prohormone convertase PC1-mediated POMC processing, and suppressed late PC2-mediated POMC processing by impairing neutral pH-dependent 7B2-proPC2 maturation. Ac45 was established as the first identified regulator of the V-ATPase proton pump.\",\n      \"method\": \"Transgenic Xenopus melanotrope cell model, acidotrophic dye assays, bafilomycin sensitivity, immunoblot analysis of POMC processing intermediates\",\n      \"journal\": \"Molecular biology of the cell\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — in vivo transgenic model with multiple orthogonal functional readouts; first mechanistic demonstration of Ac45 as V-ATPase regulator\",\n      \"pmids\": [\"20702583\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2012,\n      \"finding\": \"ATP6AP1 (Ac45) is essential for osteoclast-mediated extracellular acidification, bone resorption, lysosomal trafficking to the ruffled border, and cathepsin K exocytosis. Ac45 knockdown osteoclasts formed normal actin rings but failed to acidify extracellular space and exhibited absent lysosomal trafficking and cathepsin K exocytosis. The impaired exocytosis was specific to Ac45 deficiency, not a general V-ATPase defect. Ac45 was shown to interact with the small GTPase Rab7, suggesting a mechanism for lysosomal trafficking guidance. Ac45 knockdown also reduced osteoclast precursor proliferation and fusion via downregulation of ERK phosphorylation, c-fos, NFATc1, and Tm7sf4.\",\n      \"method\": \"siRNA knockdown in osteoclasts, bone resorption assay, extracellular acidification assay, lysosomal trafficking assay, cathepsin K exocytosis assay, co-immunoprecipitation with Rab7, RANKL-induced differentiation\",\n      \"journal\": \"Journal of bone and mineral research\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — loss-of-function with multiple specific cellular phenotype readouts and co-IP evidence for Rab7 interaction\",\n      \"pmids\": [\"22467241\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2012,\n      \"finding\": \"Domain mapping in Xenopus melanotrope cells identified that the N-terminal domain of intact Ac45 causes ER retention and poor processing, while proteolytic cleavage (generating cleaved-Ac45) enables efficient transport through the secretory pathway and V-ATPase accumulation at the plasma membrane. Removal of the C-tail from cleaved-Ac45 still permitted plasma membrane transport but abolished V-ATPase recruitment into the secretory pathway and abrogated dopaminergic inhibition of Ca2+-dependent peptide secretion. The C-tail of cleaved-Ac45 is thus specifically required for V-ATPase recruitment and regulation of Ca2+-dependent exocytosis.\",\n      \"method\": \"Transgenic Xenopus melanotrope cells expressing deletion mutants of Ac45, immunofluorescence, electron microscopy, secretion assays\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — systematic deletion mutagenesis in physiological in vivo context with multiple functional endpoints\",\n      \"pmids\": [\"22736765\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2016,\n      \"finding\": \"ATP6AP1 (Ac45) was identified as the functional human ortholog of yeast V-ATPase assembly factor Voa1. Eleven male patients with hemizygous missense mutations in ATP6AP1 displayed immunodeficiency with hypogammaglobulinemia, hepatopathy, and neurocognitive abnormalities. Processed wild-type Ac45, but not disease mutants, restored V-ATPase-dependent growth in Voa1 mutant yeast. Tissue-specific isoforms were identified: ~40 kDa processed form in brain, ~62 kDa intact form in liver, and ~50 kDa isoform in B cells, linking tissue-specific V-ATPase assembly to immunoglobulin production and cognitive function.\",\n      \"method\": \"Whole-exome sequencing, yeast complementation assay (Voa1 mutant rescue), Western blot of patient tissues, glycosylation analysis, homology detection via sequence profile comparison\",\n      \"journal\": \"Nature communications\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1/2 — yeast complementation plus patient genetics plus multiple orthogonal biochemical analyses; functionally defines Ac45 as V-ATPase assembly factor\",\n      \"pmids\": [\"27231034\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2018,\n      \"finding\": \"Whole-exome sequencing revealed mutually exclusive, clonal, inactivating somatic mutations in ATP6AP1 or ATP6AP2 in 72% of granular cell tumors (GCTs). In vitro silencing of ATP6AP1 resulted in impaired vesicle acidification, redistribution of endosomal compartments, accumulation of intracytoplasmic granules (recapitulating GCT histology), and acquisition of oncogenic properties, demonstrating that ATP6AP1 loss-of-function drives GCT tumorigenesis.\",\n      \"method\": \"Whole-exome sequencing, targeted sequencing, siRNA knockdown, lysosomal acidification assay (LysoSensor), endosomal compartment immunofluorescence, proliferation/migration/invasion assays\",\n      \"journal\": \"Nature communications\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — genomic discovery validated by in vitro loss-of-function with multiple orthogonal cellular phenotype readouts\",\n      \"pmids\": [\"30166553\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2022,\n      \"finding\": \"SARS-CoV-2 NSP6 directly interacts with ATP6AP1, a V-ATPase proton pump component, and inhibits its cleavage-mediated activation, thereby impairing lysosome acidification and blocking autophagic flux, which triggers NLRP3/ASC-dependent caspase-1 activation, IL-1β/18 maturation, and pyroptosis in lung epithelial cells. The L37F NSP6 variant (associated with asymptomatic COVID-19) showed reduced binding to ATP6AP1 and weakened ability to impair lysosome acidification. Restoration of autophagic flux by 1α,25-dihydroxyvitamin D3, metformin, or polydatin abrogated NSP6-induced pyroptosis.\",\n      \"method\": \"Co-immunoprecipitation, overexpression/knockdown studies, lysosomal acidification assay, autophagic flux assay, caspase-1 activation assay, cytokine maturation assay, live SARS-CoV-2 infection, transcriptome analysis, pharmacological rescue\",\n      \"journal\": \"Cell death and differentiation\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — direct co-IP interaction, variant binding comparison, multiple downstream functional readouts, pharmacological validation, and live virus confirmation\",\n      \"pmids\": [\"34997207\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2024,\n      \"finding\": \"ATP6AP1 was identified as an unconventional guanine nucleotide exchange factor (GEF) for the small G protein Rheb, which directly activates mTORC1. Using proximity labeling (PhastID), ATP6AP1 was found to dynamically interact with Rheb in an insulin-stimulated manner. ATP6AP1 binds Rheb through its last 12 amino acids and utilizes a tri-aspartate motif in its highly conserved C-tail to enhance Rheb GTP loading. Targeting the ATP6AP1 C-tail blocked Rheb activation and inhibited cancer cell proliferation and migration, filling the missing link in the Rheb/mTORC1 activation pathway.\",\n      \"method\": \"PhastID proximity labeling, co-immunoprecipitation, in vitro GEF activity assay (GTP loading), deletion/mutagenesis analysis of C-tail, cancer cell proliferation and migration assays\",\n      \"journal\": \"Cell research\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1/2 — proximity labeling discovery validated by co-IP, in vitro GEF assay, mutagenesis of functional motif, and cellular functional consequences\",\n      \"pmids\": [\"38448650\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2015,\n      \"finding\": \"Local AAV-mediated knockdown of ATP6AP1 (Ac45) in a periodontitis mouse model protected mice from bone erosion by >85%, reduced osteoclast-mediated extracellular acidification and bone resorption in vitro and in vivo, and attenuated gingival inflammation including decreased infiltration of T cells, dendritic cells, and macrophages, and reduced pro-inflammatory cytokine expression.\",\n      \"method\": \"AAV-mediated shRNA knockdown in mouse periodontitis model (P. gingivalis W50), histology, immunochemistry, ELISA, qRT-PCR, in vitro osteoclast acidification assay\",\n      \"journal\": \"Journal of clinical periodontology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — in vivo loss-of-function with defined bone and inflammatory phenotypes; single lab study\",\n      \"pmids\": [\"25952706\"],\n      \"is_preprint\": false\n    }\n  ],\n  \"current_model\": \"ATP6AP1 (Ac45) is a type I transmembrane accessory subunit of the V-ATPase V0 sector that undergoes furin-mediated proteolytic cleavage to become activated; the processed form guides V-ATPase trafficking through the secretory pathway, directly regulates intra-organellar (lysosomal/granular) acidification, and controls Ca2+-dependent exocytosis in neuroendocrine cells and lysosomal trafficking via Rab7 in osteoclasts; it functions as the human ortholog of yeast V-ATPase assembly factor Voa1; it additionally acts as an unconventional GEF for Rheb, thereby integrating mTORC1 activation signals at the lysosomal surface; and its interaction with SARS-CoV-2 NSP6 is exploited to impair lysosome acidification and trigger NLRP3-dependent pyroptosis, while its inactivation drives granular cell tumor oncogenesis.\"\n}\n```","stage2_raw":"```json\n{\n  \"mechanistic_narrative\": \"ATP6AP1 (Ac45) is a type I transmembrane accessory subunit of the vacuolar H+-ATPase (V-ATPase) that, following furin-mediated proteolytic cleavage in the early secretory pathway, associates with the V0 membrane sector to regulate organelle acidification, V-ATPase trafficking, and Ca²⁺-dependent exocytosis [PMID:8961292, PMID:18713856, PMID:22736765]. The intact precursor is retained in the ER by its N-terminal domain; cleavage releases the C-terminal fragment whose cytoplasmic tail is required for recruiting V-ATPase into the regulated secretory pathway and for directing lysosomal trafficking to the osteoclast ruffled border [PMID:22736765, PMID:22467241]. ATP6AP1 also functions as an unconventional guanine nucleotide exchange factor (GEF) for Rheb, using a conserved tri-aspartate motif in its C-tail to promote Rheb GTP loading and mTORC1 activation [PMID:38448650]. Loss-of-function mutations cause an X-linked immunodeficiency with hypogammaglobulinemia, hepatopathy, and neurocognitive abnormalities attributable to tissue-specific V-ATPase assembly defects [PMID:27231034].\",\n  \"teleology\": [\n    {\n      \"year\": 1996,\n      \"claim\": \"Establishing ATP6AP1 as a V-ATPase subunit resolved how the granule proton pump acquires its full complement of membrane-integral components: protein purification and Blue Native electrophoresis demonstrated that chromaffin granule glycoprotein IV (Ac45) is a precursor-derived membrane-integral subunit of the V-ATPase V0 sector.\",\n      \"evidence\": \"Protein purification from chromaffin granules, amino acid sequencing, Blue Native gel electrophoresis\",\n      \"pmids\": [\"8961292\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Stoichiometry of Ac45 within the V0 sector not determined\", \"Mechanism of precursor processing unknown\"]\n    },\n    {\n      \"year\": 1998,\n      \"claim\": \"Identification of an autonomous endocytic internalization signal in the Ac45 cytoplasmic tail revealed that its short C-terminal domain encodes sorting information independent of canonical motifs, explaining how V-ATPase complexes can be directed to intracellular compartments from the cell surface.\",\n      \"evidence\": \"Antibody-uptake internalization assays with truncation mutants and Tac chimeras in transfected cells\",\n      \"pmids\": [\"9739073\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Binding partners recognizing the internalization signal not identified\", \"Contribution of tail signal to V-ATPase targeting in vivo not tested\"]\n    },\n    {\n      \"year\": 2002,\n      \"claim\": \"Characterization of Ac45 biosynthesis defined its maturation route—N-glycosylation followed by pre-medial-Golgi cleavage—linking proteolytic processing to V-ATPase activation, while gene knockout demonstrated essentiality for early embryogenesis.\",\n      \"evidence\": \"Pulse-chase labeling with endoglycosidase H sensitivity, pharmacological inhibitors, and mouse ES cell gene targeting\",\n      \"pmids\": [\"11952786\", \"11989824\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Identity of the protease performing early-pathway cleavage was not resolved\", \"Mechanism by which cleavage activates V-ATPase remained unclear\"]\n    },\n    {\n      \"year\": 2008,\n      \"claim\": \"Two studies converged to show that furin is the protease cleaving Ac45 and that the cleaved form drives V-ATPase into the regulated secretory pathway: furin cleavage was demonstrated ex vivo and its loss impaired β-cell acidification and insulin secretion, while transgenic overexpression in Xenopus melanotropes accumulated V-ATPase at the plasma membrane and enhanced Ca²⁺-dependent exocytosis.\",\n      \"evidence\": \"Ex vivo furin cleavage assay, furin-KO mouse β-cells, siRNA in insulinoma cells, transgenic Xenopus melanotrope expression with immunoelectron microscopy and secretion assays\",\n      \"pmids\": [\"18713856\", \"18657579\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether furin cleavage is the sole activating event or additional processing occurs was unresolved\", \"How cleaved Ac45 mechanistically recruits V-ATPase to secretory granules was unknown\"]\n    },\n    {\n      \"year\": 2010,\n      \"claim\": \"Demonstrating that Ac45 overexpression increased granular acidification and altered prohormone processing established Ac45 as the first identified positive regulator of V-ATPase proton pump activity in a physiological context.\",\n      \"evidence\": \"Transgenic Xenopus melanotrope cells with granular acidification assay, V-ATPase inhibitor sensitivity, POMC/PC1/PC2 processing analysis\",\n      \"pmids\": [\"20702583\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether Ac45 enhances V-ATPase assembly, recruitment, or intrinsic activity was not distinguished\"]\n    },\n    {\n      \"year\": 2012,\n      \"claim\": \"Domain-mapping studies and osteoclast knockdown experiments dissected Ac45's dual functionality: the N-terminal domain retains the intact precursor in the ER, the C-tail of cleaved Ac45 is specifically required for V-ATPase recruitment into the secretory pathway and Ca²⁺-dependent exocytosis, and in osteoclasts Ac45 directs lysosomal trafficking to the ruffled border independently of general V-ATPase effects.\",\n      \"evidence\": \"Transgenic Xenopus deletion mutant series with secretion/localization readouts; siRNA knockdown in osteoclasts with bone resorption, lysosomal trafficking, and cathepsin K exocytosis assays\",\n      \"pmids\": [\"22736765\", \"22467241\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Rab7 interaction suggested in osteoclasts but not directly validated\", \"Whether the C-tail interacts with coat proteins or adaptors for secretory pathway entry is unknown\"]\n    },\n    {\n      \"year\": 2016,\n      \"claim\": \"Showing that human Ac45 rescues yeast Voa1 loss and that patient missense mutations abolish this rescue established ATP6AP1 as a conserved V-ATPase assembly factor and identified it as the gene responsible for an X-linked immunodeficiency with hepatopathy.\",\n      \"evidence\": \"Yeast Voa1-mutant complementation with wild-type vs. patient-mutant Ac45, patient genotyping, tissue-specific isoform analysis\",\n      \"pmids\": [\"27231034\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Structural basis of assembly factor activity not resolved\", \"How tissue-specific isoforms explain organ-selective disease manifestations is unclear\"]\n    },\n    {\n      \"year\": 2018,\n      \"claim\": \"Discovery that somatic ATP6AP1 loss-of-function mutations drive granular cell tumors extended its role beyond assembly factor to tumor suppressor: knockdown phenocopied GCT hallmarks including impaired acidification, endosomal redistribution, and granule accumulation.\",\n      \"evidence\": \"Whole-exome and targeted sequencing of GCTs, siRNA knockdown with acidification, endosomal imaging, and oncogenic property assays\",\n      \"pmids\": [\"30166553\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Oncogenic mechanism downstream of acidification defects not elucidated\", \"Whether ATP6AP1 mutations cooperate with other drivers is unknown\"]\n    },\n    {\n      \"year\": 2022,\n      \"claim\": \"Identifying ATP6AP1 as a direct target of SARS-CoV-2 NSP6 revealed a viral strategy to impair lysosomal acidification: NSP6 inhibits Ac45 cleavage-mediated activation, blocking autophagic flux and triggering NLRP3-dependent pyroptosis in lung epithelial cells.\",\n      \"evidence\": \"Co-immunoprecipitation of NSP6–ATP6AP1, L37F mutagenesis reducing binding, lysosome acidification, autophagic flux, and caspase-1 activation assays in live SARS-CoV-2 infection\",\n      \"pmids\": [\"34997207\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether other viral proteins synergize with NSP6 to disable V-ATPase is untested\", \"Direct structural interface between NSP6 and ATP6AP1 not mapped\"]\n    },\n    {\n      \"year\": 2024,\n      \"claim\": \"Revealing that ATP6AP1 functions as a GEF for Rheb via its C-terminal tri-aspartate motif uncovered a V-ATPase-independent signaling role, linking lysosomal membrane Ac45 directly to mTORC1 activation and cancer cell proliferation.\",\n      \"evidence\": \"PhastID proximity labeling, Co-IP, in vitro Rheb GTP-loading GEF assay, tri-aspartate mutagenesis, cancer cell proliferation and migration assays\",\n      \"pmids\": [\"38448650\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether GEF activity and V-ATPase assembly functions are coordinated or independent is unknown\", \"Structural basis of the Ac45–Rheb catalytic interaction not determined\", \"In vivo validation of GEF function in animal models is lacking\"]\n    },\n    {\n      \"year\": null,\n      \"claim\": \"Key unresolved questions include: how the V-ATPase assembly factor and Rheb GEF functions of ATP6AP1 are coordinated at the lysosomal membrane, the structural basis of Ac45 within the V0 sector, and the molecular mechanism by which tissue-specific Ac45 isoforms produce organ-selective disease phenotypes.\",\n      \"evidence\": \"\",\n      \"pmids\": [],\n      \"confidence\": \"Low\",\n      \"gaps\": [\"No high-resolution structure of Ac45 in the V-ATPase complex\", \"Coordination between GEF and assembly functions unexplored\", \"Tissue-specific isoform regulation and functional divergence undefined\"]\n    }\n  ],\n  \"mechanism_profile\": {\n    \"molecular_activity\": [\n      {\"term_id\": \"GO:0098772\", \"supporting_discovery_ids\": [0, 5, 6, 7, 8, 13]},\n      {\"term_id\": \"GO:0005215\", \"supporting_discovery_ids\": [5, 6, 14]},\n      {\"term_id\": \"GO:0140096\", \"supporting_discovery_ids\": [3]}\n    ],\n    \"localization\": [\n      {\"term_id\": \"GO:0005764\", \"supporting_discovery_ids\": [2, 3, 4]},\n      {\"term_id\": \"GO:0005886\", \"supporting_discovery_ids\": [6, 12, 13]},\n      {\"term_id\": \"GO:0031410\", \"supporting_discovery_ids\": [1, 6, 14]},\n      {\"term_id\": \"GO:0005783\", \"supporting_discovery_ids\": [10, 13]},\n      {\"term_id\": \"GO:0005794\", \"supporting_discovery_ids\": [10]}\n    ],\n    \"pathway\": [\n      {\"term_id\": \"R-HSA-9612973\", \"supporting_discovery_ids\": [2]},\n      {\"term_id\": \"R-HSA-382551\", \"supporting_discovery_ids\": [5, 6, 8, 14]},\n      {\"term_id\": \"R-HSA-162582\", \"supporting_discovery_ids\": [3]},\n      {\"term_id\": \"R-HSA-5653656\", \"supporting_discovery_ids\": [4, 6, 12, 13]},\n      {\"term_id\": \"R-HSA-1643685\", \"supporting_discovery_ids\": [0, 1, 2]},\n      {\"term_id\": \"R-HSA-392499\", \"supporting_discovery_ids\": [8, 10]}\n    ],\n    \"complexes\": [\"V-ATPase (V0 sector)\"],\n    \"partners\": [\"ATP6V0A1\", \"Rheb\", \"FURIN\", \"NSP6\", \"RAB7\"],\n    \"other_free_text\": []\n  }\n}\n```\n\n--- ROUND 2 (R2/R3, augmented corpus) ---\n\n```json\n{\n  \"mechanistic_narrative\": \"ATP6AP1 (Ac45) is an accessory subunit of the V0 sector of the vacuolar H⁺-ATPase that functions as a V-ATPase assembly factor, trafficking guide, and signaling integrator at endomembranes. Synthesized as an N-glycosylated precursor, it undergoes furin-mediated proteolytic cleavage in the secretory pathway; the processed C-terminal form directs V-ATPase through the secretory pathway to regulate organellar and extracellular acidification, Ca²⁺-dependent exocytosis in neuroendocrine cells, and lysosomal trafficking via Rab7 interaction in osteoclasts [PMID:18713856, PMID:20702583, PMID:22736765, PMID:22467241]. ATP6AP1 additionally acts as an unconventional guanine nucleotide exchange factor for Rheb, coupling V-ATPase-associated lysosomal signaling to mTORC1 activation through a conserved tri-aspartate motif in its cytoplasmic tail [PMID:38448650]. Hemizygous missense mutations in ATP6AP1 cause an X-linked syndrome of immunodeficiency with hypogammaglobulinemia, hepatopathy, and neurocognitive abnormalities, while somatic inactivating mutations drive granular cell tumor oncogenesis [PMID:27231034, PMID:30166553].\",\n  \"teleology\": [\n    {\n      \"year\": 1996,\n      \"claim\": \"Establishing ATP6AP1 as a V-ATPase subunit resolved the identity of chromaffin granule glycoprotein IV and placed it within the V0 membrane sector, opening the question of what regulatory role an accessory subunit plays in proton pump function.\",\n      \"evidence\": \"Biochemical purification, amino acid sequencing, and Blue Native electrophoresis of bovine chromaffin granule membranes\",\n      \"pmids\": [\"8961292\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"No functional assay for pump activity modulation\", \"Cleavage site and protease not yet defined\", \"Mechanism of V0 incorporation unknown\"]\n    },\n    {\n      \"year\": 1999,\n      \"claim\": \"Demonstrating that Ac45 is synthesized as a glycosylated precursor cleaved to a mature form enriched in neuroendocrine tissues established a biosynthetic framework and suggested that proteolytic processing activates the protein for its V-ATPase regulatory role.\",\n      \"evidence\": \"Biosynthetic pulse-chase labeling, deglycosylation, and immunocytochemistry in Xenopus pituitary; complemented by pharmacological dissection in 2002\",\n      \"pmids\": [\"10336633\", \"11952786\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Identity of the protease responsible for cleavage unknown\", \"Functional consequence of cleavage not yet tested\"]\n    },\n    {\n      \"year\": 2002,\n      \"claim\": \"Gene targeting showed that Ac45 is essential for mouse embryonic development, establishing it as a non-redundant gene required for fundamental cellular viability rather than a dispensable accessory factor.\",\n      \"evidence\": \"Homologous recombination knockout in ES cells with blastocyst injection chimera analysis\",\n      \"pmids\": [\"11989824\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Mechanism of embryonic lethality uncharacterized\", \"Tissue-specific requirements not dissected\", \"No conditional knockout to separate early vs. late functions\"]\n    },\n    {\n      \"year\": 2008,\n      \"claim\": \"Two advances established the mechanistic basis of Ac45 function: transgenic overexpression showed Ac45 guides V-ATPase to the plasma membrane and enhances Ca²⁺-dependent exocytosis, while identification of furin as the activating protease linked cleavage to granule acidification and regulated secretion in pancreatic beta cells.\",\n      \"evidence\": \"Transgenic Xenopus melanotrope cells with EM, secretion assays; conditional furin knockout mice with ex vivo cleavage assay and siRNA knockdown in insulinoma cells\",\n      \"pmids\": [\"18657579\", \"18713856\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Structural basis of furin recognition site not resolved\", \"Whether other proprotein convertases can substitute for furin in vivo\"]\n    },\n    {\n      \"year\": 2010,\n      \"claim\": \"Direct measurement of granular pH established Ac45 as the first identified positive regulator of V-ATPase proton pumping, showing it controls differential prohormone processing by tuning compartmental acidity.\",\n      \"evidence\": \"Acidotrophic dye assays and bafilomycin sensitivity in transgenic Xenopus melanotrope cells with immunoblot of POMC processing intermediates\",\n      \"pmids\": [\"20702583\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether Ac45 alters V-ATPase catalytic rate vs. surface density not distinguished\", \"No reconstituted in vitro pump activity assay\"]\n    },\n    {\n      \"year\": 2012,\n      \"claim\": \"Domain mapping revealed that furin cleavage liberates the processed form for efficient secretory pathway transit, and that the cytoplasmic C-tail is specifically required for V-ATPase recruitment and regulation of exocytosis, defining the minimal functional architecture of Ac45.\",\n      \"evidence\": \"Systematic deletion mutagenesis of Ac45 domains in transgenic Xenopus melanotrope cells with localization and secretion readouts\",\n      \"pmids\": [\"22736765\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Binding partners of the C-tail not identified\", \"Structural basis of C-tail–V-ATPase interaction unknown\"]\n    },\n    {\n      \"year\": 2012,\n      \"claim\": \"Extending Ac45 function to osteoclasts showed it is required for extracellular acidification, bone resorption, and cathepsin K exocytosis via interaction with Rab7, demonstrating a lysosomal trafficking guidance role beyond neuroendocrine secretion.\",\n      \"evidence\": \"siRNA knockdown in osteoclasts with bone resorption, extracellular acidification, lysosomal trafficking, and cathepsin K exocytosis assays; co-immunoprecipitation with Rab7\",\n      \"pmids\": [\"22467241\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Direct vs. indirect nature of Rab7 interaction not resolved\", \"No structural data on Ac45–Rab7 interface\", \"Rab7 GEF/GAP mechanism not tested\"]\n    },\n    {\n      \"year\": 2015,\n      \"claim\": \"In vivo AAV-mediated knockdown of Ac45 in a periodontitis model validated the osteoclast findings and revealed additional anti-inflammatory effects, suggesting broader roles in immune cell regulation at sites of bone erosion.\",\n      \"evidence\": \"AAV-shRNA knockdown in mouse periodontitis model with histology, immunochemistry, cytokine profiling, and in vitro osteoclast assays\",\n      \"pmids\": [\"25952706\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Single-lab study not independently replicated\", \"Inflammatory effects may be secondary to impaired osteoclast function rather than direct immune regulation\", \"Off-target AAV effects not fully excluded\"]\n    },\n    {\n      \"year\": 2016,\n      \"claim\": \"Identification of ATP6AP1 as the human ortholog of yeast Voa1 and discovery that hemizygous missense mutations cause X-linked immunodeficiency with hepatopathy and neurocognitive disease unified the V-ATPase assembly function with human pathology and revealed tissue-specific Ac45 isoforms.\",\n      \"evidence\": \"Whole-exome sequencing of 11 male patients, yeast Voa1 complementation assay with wild-type vs. mutant Ac45, Western blot of patient tissues\",\n      \"pmids\": [\"27231034\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Structural basis of disease-causing mutations not determined\", \"Tissue-specific isoform generation mechanism unknown\", \"No mouse model recapitulating the full human phenotype\"]\n    },\n    {\n      \"year\": 2018,\n      \"claim\": \"Discovery of recurrent somatic inactivating mutations in ATP6AP1 in granular cell tumors, validated by silencing-induced impaired acidification and oncogenic phenotypes, established ATP6AP1 as a tumor suppressor whose loss drives a specific tumor type.\",\n      \"evidence\": \"Whole-exome and targeted sequencing of GCTs; siRNA knockdown with lysosomal acidification, endosomal redistribution, and proliferation/migration/invasion assays\",\n      \"pmids\": [\"30166553\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Mechanism linking impaired acidification to oncogenic transformation not defined\", \"No in vivo tumor model with Ac45 loss\", \"Relationship between GCT mutations and V-ATPase assembly not tested\"]\n    },\n    {\n      \"year\": 2022,\n      \"claim\": \"SARS-CoV-2 NSP6 was shown to directly bind ATP6AP1 and inhibit its cleavage-mediated activation, impairing lysosome acidification and triggering NLRP3-dependent pyroptosis—revealing Ac45 as a viral target for immune evasion.\",\n      \"evidence\": \"Co-immunoprecipitation, lysosomal acidification and autophagic flux assays, caspase-1 activation, live SARS-CoV-2 infection, and pharmacological rescue in lung epithelial cells\",\n      \"pmids\": [\"34997207\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Structural interface of NSP6–ATP6AP1 interaction not resolved\", \"Whether other coronaviruses exploit the same mechanism is untested\", \"Relative contribution of ATP6AP1 vs. other NSP6 targets to COVID-19 pathology unclear\"]\n    },\n    {\n      \"year\": 2024,\n      \"claim\": \"Identification of ATP6AP1 as an unconventional GEF for Rheb via its conserved C-terminal tri-aspartate motif provided a direct mechanistic link between V-ATPase-associated lysosomal signaling and mTORC1 activation, filling a long-standing gap in Rheb regulation.\",\n      \"evidence\": \"PhastID proximity labeling, co-immunoprecipitation, in vitro GEF assay, C-tail mutagenesis, cancer cell proliferation and migration assays\",\n      \"pmids\": [\"38448650\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Structural basis of Ac45–Rheb GEF activity not resolved\", \"Whether V-ATPase proton pumping is coupled to or independent of the GEF function\", \"In vivo genetic validation of the GEF function in animal models pending\"]\n    },\n    {\n      \"year\": null,\n      \"claim\": \"Key unresolved questions include the structural basis of the ATP6AP1 C-tail's dual function in V-ATPase recruitment and Rheb GEF activity, the mechanism generating tissue-specific Ac45 isoforms, and whether the V-ATPase assembly and mTORC1 signaling roles are coordinated or independent.\",\n      \"evidence\": \"\",\n      \"pmids\": [],\n      \"confidence\": \"Low\",\n      \"gaps\": [\"No high-resolution structure of Ac45 in complex with V0 or Rheb\", \"Tissue-specific isoform biogenesis mechanism unknown\", \"Coupling between proton pump regulation and mTORC1 GEF function untested\"]\n    }\n  ],\n  \"mechanism_profile\": {\n    \"molecular_activity\": [\n      {\"term_id\": \"GO:0005198\", \"supporting_discovery_ids\": [0, 10]},\n      {\"term_id\": \"GO:0098772\", \"supporting_discovery_ids\": [5, 7, 9]},\n      {\"term_id\": \"GO:0060090\", \"supporting_discovery_ids\": [8, 9]},\n      {\"term_id\": \"GO:0060089\", \"supporting_discovery_ids\": [13]}\n    ],\n    \"localization\": [\n      {\"term_id\": \"GO:0005886\", \"supporting_discovery_ids\": [1, 5, 9]},\n      {\"term_id\": \"GO:0005764\", \"supporting_discovery_ids\": [8, 11, 12]},\n      {\"term_id\": \"GO:0031410\", \"supporting_discovery_ids\": [1, 2, 5]},\n      {\"term_id\": \"GO:0005783\", \"supporting_discovery_ids\": [4, 9]},\n      {\"term_id\": \"GO:0005794\", \"supporting_discovery_ids\": [4, 6]}\n    ],\n    \"pathway\": [\n      {\"term_id\": \"R-HSA-382551\", \"supporting_discovery_ids\": [0, 5, 7, 8]},\n      {\"term_id\": \"R-HSA-5653656\", \"supporting_discovery_ids\": [5, 8, 9]},\n      {\"term_id\": \"R-HSA-162582\", \"supporting_discovery_ids\": [13]},\n      {\"term_id\": \"R-HSA-1643685\", \"supporting_discovery_ids\": [10, 11]},\n      {\"term_id\": \"R-HSA-392499\", \"supporting_discovery_ids\": [4, 6, 10]},\n      {\"term_id\": \"R-HSA-9612973\", \"supporting_discovery_ids\": [12]},\n      {\"term_id\": \"R-HSA-168256\", \"supporting_discovery_ids\": [10, 14]}\n    ],\n    \"complexes\": [\n      \"V-ATPase V0 sector\"\n    ],\n    \"partners\": [\n      \"RAB7A\",\n      \"RHEB\",\n      \"FURIN\",\n      \"ATP6V0A1\"\n    ],\n    \"other_free_text\": []\n  }\n}\n```"}